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Abstract 
Cardiovascular diseases are among the leading causes of disability in low- and middle-income 
countries (LMICs). Cardiac rehabilitation (CR) is an effective secondary prevention program 
model. In this cross-sectional study, a confidential, online survey was administered to CR 
programs around the world. CR programs were identified in 55/138 (39.9%) LMICs; 47 (85.5% 
country response rate) countries participated and 335(53.5% program response rate) surveys 
were initiated. There was 1 CR spot for every 66 incident ischemic heart disease patients in 
LMICs. CR was most often paid by patients in LMICs (n=212,65.0%). On average, programs 
offered 7.3±1.8/11 core components over 33.7±30.7 sessions (significantly greater in publicly-
funded programs;p<.001). Lack of patient referral (3.8/5) and financial resources (3.5/5) were the 
greatest barriers to CR provision in LMICs. CR is only available in 40% of LMICs, but where 
offered is fairly consistent with CR guidelines.  Governments must enact policies to reimburse 
CR so patients do not pay out-of-pocket. 
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INTRODUCTION 
Cardiac rehabilitation (CR) is an essential part of the continuum of care for patients with 
cardiovascular disease (CVD), given the well-established benefits of participation1. CR is offered 
in 83 out of the 196 countries around the globe2. Provision at the national level have been well 
described in published survey results in Europe, as well as in North America. Standards for CR 
delivery have also been established on these continents3–7 .  
Cardiac rehabilitation (CR) is a proven model of care for secondary prevention. It is 
comprised of several core components, delivered by a multi-disciplinary team.8,9 Participation in 
CR reduces CVD mortality and hospital re-admission by approximately 20%, as well as 
improves quality of life,10 with more CR associated with better outcomes. Accordingly, it is a 
recommendation in clinical practice guidelines for CVD,11 revascularization,12,13 and heart 
failure (HF)14 patients, with robust evidence of benefit also in valve patients,15 transplant,16 and 
atrial fibrillation.17  
In low and middle-income countries (LMICs) where the epidemic of CVD is at its worst, 
little is known about the availability of CR and the models for its delivery2,18.  In the few  
available  publications regarding CR in LMICs, results revealed variability in the source of 
funding and delivery of core components, however major barriers such as lack of 
human/financial resources were comparable across settings19–22. There are also major geographic 
disparities in the publications with the majority of studies from Europe and South America and 
little data from Asia and Africa. Clearly, little is known about CR delivery in these countries 
heavily burdened by CVD. The purpose of this thesis is to characterize the nature of CR in 
LMICs, as well as the barriers to delivery to inform policy and strategies to broaden delivery. 
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LITERATURE REVIEW  
Cardiovascular disease (CVD) refers to a class of diseases that involve the heart or blood vessels. 
CVD is the leading cause of death globally, with over 17 million deaths annually23. At the same 
time, with the advancements in medical technology, more patients are surviving cardiac events-- 
however these patients are at a higher risk of another event24. Moreover, CVD is among the 
leading causes of disability around the world 25. The number of people living with chronic CVD 
is increasing and it now contributes to 10% of disability adjusted life years (DALYs) lost world-
wide 26. CVD imposes a huge economic burden on health systems as a result of the direct and 
indirect costs (cost of health care services, medications, and lost productivity 27) associated with 
mortality and morbidity 28. Clearly there is a great need for effective secondary prevention.  
While CVD has historically been a challenge in high-income countries due to factors such as 
expansion of the fast food industry and greater reliance on sedentary forms of travel, over the 
past two decades, CVD death rates have increased at an alarming rate in economically-
disadvantaged countries, or LMICs. Indeed, with better control of communicable diseases and 
rapid urbanization in LMICs, more than 80% of the world's CVD deaths now occur in these 
countries25.  
Countries are classified according to their economy using 2017 Gross National Income (GNI) 
per capita in United States Dollars (USD) purchasing power parity (PPP), in accordance with 
World Bank methodology29. Low-income countries are those with GNI per capita of $1,025 or 
less. Lower middle-income countries have a GNI per capita between $1,026 and $4,035 and 
upper middle-income countries are those with a GNI per capita between $4,036 and $12,47529. 
Of the 196 countries globally, 138 are LMICs: 30 low-income, 53 lower middle-income and 55 
upper middle-income.  
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Cardiac Rehabilitation  
CR is a multidisciplinary approach to secondary prevention designed to stabilize, slow, or 
promote regression of CVD to reduce the risk of a future cardiac event30. It is defined by the 
World Health Organization (WHO) as the “sum of activities required to influence favourably the 
underlying cause of the disease, as well as to provide the best possible physical, mental and 
social conditions, so that the patients may, by their own efforts, preserve or resume when lost, as 
normal a place as possible in the community”31. CR programs offer medical assessment, 
structured exercise training, patient and family education, and delivery of comprehensive 
management strategies of CV risk factors (lipids, hypertension, weight, diabetes mellitus, and 
smoking)32. It is recommended CR be initiated before discharge for a cardiac condition (i.e., 
Phase I), then be offered more comprehensively to outpatients (i.e., Phase II), and that patients 
maintain their behavior changes long-term (i.e., Phase III).   
 Many randomized controlled trials and major meta-analyses have shown that 
participation in CR promotes a healthy lifestyle, reduces risk factors, improves health-related 
quality of life, and decreases morbidity and mortality by approximately 25% 33–36. It is a class 1 
level A recommendation in clinical practice guidelines for cardiac patients 37–41. CR is also 
proven to be a cost-effective secondary prevention strategy42.  
Cardiac Rehabilitation in Low- and Middle-Income Countries 
CR is available in 82.4% of high-income countries, but only 53 (50.0%) of MICs and 7 
(22.6%) of LICs2. Based on this review of the availability of CR globally, and 3 other reviews of 
CR in LMICs2,18,43, the 60 LMICs where CR is suspected or known to be offered are shown in 
Table 1. Using World Bank classifications, there are programs in 6 (75.0%) South Asian LMICs, 
8 (16.7%) in Sub-Saharan Africa, 14 (43.8%) in East Asia and Pacific, 45 (80.4%) in Europe and 
Central Asia, 37 (70.3%) in Latin America and the Caribbean, 14 (66.7%) in the Middle East and 
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North Africa and 3 (100%) in North America. Clearly, more programs are needed, but we must 
understand more about the nature of services and barriers to delivery to support broader 
implementation. 
The handful of primary studies on CR benefits from LMICs suggest that positive 
outcomes are achieved and the magnitude of these benefits are similar to those established in 
high-income countries44. Specifically, participation in CR is associated with significant reduction 
in triglycerides45–47, total cholesterol45–47, LDL45,47,48, body mass index46–48, as well as 
systolic45,48, and diastolic blood pressure45. CR is also associated with significant increases in 
HDL47,48. Additionally, some studies revealed significant improvements in health-related quality 
of life49–52, self-efficacy49, self-regulation49, and functional capacity47,48,52. No studies have 
assessed mortality or morbidity outcomes in LMICs, but the changes in risk factor profiles and 
health behaviours have been strongly associated with mortality reductions53. 
To better address the global burden of CVD, CR programs must be universally available 
and be of high-quality. Consensus guidelines for CR delivery for lower resource settings have 
been developed for a global perspective8,9, Europe54, China (personal communication, R. Ding), 
and South America55. A review of the literature revealed there have been 4 English-language 
primary studies reporting on the availability and nature of CR services on a national or regional 
basis in LMICs, reporting on 10 (16.7%) of the LMICs of the world. There was 1 English-
language abstract identified from Mexico56. While the full publication was not available in 
English, there were 2 English publications providing some summative views on services 
there19,57. Another survey of CR programs in the Arab world included a response from an 
Egyptian program58, but results were not reported separately for this country. There was also 1 
paper describing CR in Thailand21, and another in South America22. This covers 11 (18.3%) of 
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the 60 LMICs where CR is known to be offered. Below these studies are reviewed (by World 
Bank region), with a corresponding summary of findings shown in Table 2.  
CR Delivery in East Asia and the Pacific 
As shown in Table 1, there has been 1 primary study in this region, namely in China. One 
descriptive paper was identified related to Thailand. The survey in China was completed by 13 
CR programs, where 10 (76.9%) had comprehensive phase II programs59. Findings indicated CR 
programs were only available in 24.0% of hospitals. CR teams were composed of physicians 
(100.0%), nurses (84.6%), dietitians (46.2%), clinical educators (30.8%), exercise physiologists 
(15.4%), and psychologists (15.4%). The core components that were offered in all programs 
were clinical assessment, physical activity and exercise training counseling, dietary counseling 
and tobacco cessation interventions. CR programs accepted patients with heart failure (100.0%), 
post-percutaneous coronary intervention (PCI) (100.0%), post-myocardial infarction (MI) 
(92.3%), with pacemakers (92.3%) and post-coronary artery bypass graft surgery (CABG) 
(69.2%). Major barriers to delivering CR were lack of interest (58.0%), human resources 
(58.0%), awareness (50.0%), and space (47.0%).  
The paper describing the status of CR in Thailand reported the existence of 5 programs21. 
Phase was not specified. These programs offered exercise and lifestyle modification. The barriers 
to patient participation in CR listed were time constraints, transportation, and lack of a caregiver 
to take them. 
CR Delivery in Latin America and the Caribbean  
There have been 3 studies in this region, with CR programs surveyed in Argentina, Brazil, Chile, 
Colombia, Costa Rica, Ecuador, Mexico, Paraguay, Peru, Uruguay and Venezuela. All but Chile 
and Uruguay are LMICs. These are described in turn below. 
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The first survey conducted in Latin America and the Caribbean was completed by 33 
comprehensive phase II programs19. Results showed that program duration was between 11 and 
15 weeks in most centers (66.0%), and session frequency was mainly 2 to 3 sessions per week 
(94.0%). Programs served ≤2000 patients per year in 81% of centers, and were funded by 
hospitals (24.0%), social security (24.0%), and private insurance (24.0%). CR teams were 
composed of cardiologists (100.0%), physiotherapists (94.0%), dietitians (91.0%), nurses 
(52.0%) and psychologists (48.0%). Programs accepted patients post-MI (100.0%), post-PCI 
(97.0%), post-CABG (97.0%), with valvular conditions (82.0%) and heart failure (73.0%). 
Alternative CR models were offered, most commonly community-based (48.0%). Major barriers 
to CR implementation were lack of trained personnel (41.0%), lack of funding (33.0%), and lack 
of space (13.0%).  
The second survey in South America was completed by 107 comprehensive phase II CR 
programs20. Findings indicated that CR programs served an average of 180 patients per year and 
were funded by a mix of sources (46.0%), private insurance (19.0%), patients (18.0%) and 
hospitals (9.0%). CR teams were composed of cardiologists (100.0%), nutritionists (72.0%), 
physical therapists (72.0%), psychologists (53%) and nurses (50.0%). Core components that 
were offered in many phase II programs were physical activity counseling (100.0%), exercise 
planning (99.0%), exercise training (97.0%), risk factor management (96.0%) and nutrition 
counseling (91.0%). Programs accepted patients post-MI (100.0%), post-PCI (99.0%), post-
CABG (97.0%), with heart failure (97.0%) and with valvular disease (95.0%). Barriers to CR 
were lack of economic resources (12.8%), lack of space (6.2%), and transportation issues 
(13.0%).  
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Two surveys were conducted in Mexico56,57. The most recent survey was completed by 
24 (100%) phase II programs57. Results showed that almost all programs delivered the core CR 
components, and patients were the main source of funding for CR. Findings indicated that CR 
teams were mainly composed of physicians (100%), administrative assistants (100%), physical 
therapists (83.3%), nurses (79.1%) and nutritionists (79.1%). The core components that were 
offered in many phase II programs were exercise training (100%), dietary counselling (90.0%), 
and psychological support (80.0%). Programs accepted patients with ischemic heart disease 
(100%), post-PCI (100%), with heart failure (91.7%), post-CABG (87.5%) and with valvular 
disease (83.3%). Alternative CR models were offered, most commonly home-based (10.3%). 
Major barriers indicated were lack of finances (83.0%), lack of trained personnel (67.0%), lack 
of functional equipment (46.0%), lack of space (42.0%) and a reduction in operating centers 
(38.0%). 
Finally, the narrative review on CR in South America also reported source of 
reimbursement for services22. While there were some publically-funded programs, there were 
also many privately-run centers. The costs to deliver these were shown to differ. Differences in 
the nature of the programs that might explain this were not reported. 
The survey results reveal: (1) that we do not know about the nature of services in most 
LMICs, and (2) where it is offered there are some consistencies with CR guidelines and 
standards8,9,55. What is known about CR delivery in LMICs stems from East Asia, Latin America 
and the Caribbean. There is a major gap in knowledge of CR in LMICs in Europe and Central 
Asia, Middle East and North Africa, South Asia, and Sub-Saharan Africa. Similarities are seen in 
the components offered in CR programs, such as physical activity, patient education and 
nutrition counseling. The health professional most involved in CR delivery were quite 
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consistently nurses, cardiologists and physiotherapists. Main diagnoses accepted into CR were 
MI and PCI. The main barrier to CR implementation was lack of financial resources.  
Objectives 
The aims of this thesis were to assess: (1) availability, volume, capacity and density of CR, (2) 
nature of CR programs, as well as (3) barriers to CR delivery in LMICs, and compare these (a) to 
high-income countries (HIC) and (b) by funding source. 
METHODS 
Design 
This thesis was quantitative and cross-sectional in design. Data was gathered form an online 
survey that was emailed to CR programs identified globally. The study was approved by York 
University’s Office of Research Ethics (Toronto, Canada) and Mayo Clinic’s Institutional 
Review Board (Rochester, United States). 
Sample 
The sample consisted of all CR programs identified around the world that offered services to 
outpatients (e.g., Phase II). Only those in LMICs (according to World Bank categorization as 
outlined above) were used for objectives 1, 2 and 3, while responses were compared to those in 
high-income countries for objectives 1(a), 2(a), and 3(a). CR programs included were those that 
offered: (1) initial patient assessment, (2) structured exercise (supervised or not), and (3) at least 
one other strategy to control risk factors. This included residential programs. Where ≤350 CR 
CR programs existed in a given country, 250 were randomly selected for inclusion. There were 
no exclusion criteria. 
 Individual CR programs were identified on a national basis following a systematic 
process. First, a MS Excel spreadsheet of countries which offer CR (as identified in previous 
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reviews2,18) was generated. An internet search for CR in all other countries not known to offer 
CR was performed to ensure the list of countries was current.  
Second, through further internet searching of established healthcare societies, national 
CR associations or organizations were identified for each country known to offer CR. The chair 
of the society was identified and their email address secured. If no national CR society existed, 
next Cardiology, then Physical Medicine & Rehabilitation, or “continental” associations of the 
WHO in the CR field for a given country was identified from peer-reviewed CR literature, the 
internet or through International Council of Cardiovascular Prevention and Rehabilitation 
(www.globalcardiacrehab.com) contacts.  
Finally, the first key contact for each country was emailed requesting their collaboration 
in the study. Where ≥10 programs were perceived to exist, the contact was offered co-authorship 
and provision of comparative country-specific information on CR.  Agreeing 
societies/champions collated email contact information for all known programs in their country, 
and provided the total number of programs in their country. Where no society or champion were 
identified in a country where CR exists, individual programs were identified via Google search.  
Procedure 
The most responsible clinician of the identified CR programs was sent an e-mail requesting 
her/his participation and a link to the survey. This was sent by the participating society / 
champion or study investigators, depending on the will of the society / CR champion.  
The survey was administered through a web-based program (REDCap).  First, informed 
consent was sought through an online consent form (see appendix A). Respondents were 
required to click a box to consent, and then they could proceed to complete the survey. The 
survey was confidential.  
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Non-respondents were sent 2 follow-up email reminders at 2 week intervals. National CR 
association representatives / champions were engaged to optimize response rate where below 
40%.  
Respondents were offered summative feedback on CR delivery in their country in return 
for their participation. They provided their email address upon completion of the survey if they 
elected to receive this feedback.  
Measures 
The CR program survey was developed based on previous national CR surveys developed in 
Canada and by collaborators 20,58,60–62. The non-English surveys were translated to English. The 
investigative team underwent a process of integrating overlapping content, review and approval 
of a “reference survey”. It was pilot-tested in Canada and Arab countries58. It was revised based 
on the pilot test and recent literature, with the final version shown in Appendix B.  
The survey was translated into Spanish, Portuguese and traditional Chinese character to 
facilitate survey comprehension and completion by respondents for whom these are their first-
language (funding was not available for further translations). 
 The survey was composed of open-ended and multiple-choice questions to collect both 
qualitative and quantitative information. Item 2 was country, which was used to categorize the 
program as LMIC or HIC (objectives 1[a], 2[a], and 3[a]). As per objective 2, items were 
designed to assess: (1) location of the program in the healthcare system (items 7-10,15-16); (2) 
how CR is funded / reimbursed (item 6; for objectives 1[b], 2[b], and 3[b]); (3) program 
availability, volume, capacity and density (items 12-13; objective 1); (4) healthcare professionals 
on the CR team (items 18, 24, 38); (5) components delivered (items 20, 23, 27, 39); (6) nature of 
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patients served (items 28-30); (7) alternative models delivered (section D); and (8) barriers to 
delivery (item 17; objective 3).  
CR program volume was defined as number of patients served annually. Program 
capacity was defined as the median number of patients a program could serve annually; this was 
also multiplied by the number of programs in the country (ascertained from champion) to 
determine national CR capacity. Finally, national density was national capacity divided by 2016 
estimated incidence of ischemic heart disease (IHD) (ascertained from Global Burden of Disease 
study)63. 
Respondents were provided 5 options for funding sources, and instructed to check all that 
apply. “Other” responses were categorized, and classified as private or public sources (e.g., 
foundations classified as private). To categorize funding source, respondents that selected the 
“patient” and/or “private health insurance” options only were categorized as “private”; those that 
selected the “social security/government” and/or “hospital/clincial center” options only were 
classified as “public”; those that selected one or more of both the above private and public 
response options were categorized as “hybrid”. National funding source was also computed, 
classified as the most frequent of the 3 options from all responses in a given country. 
Statistical Analysis 
Data was analyzed using IBM SPSS 24 and p<.05 considered significant. All initiated 
surveys were included. The number of responses for each question varied due to missing data 
(e.g., respondent did not answer a question due to lack of willingness or potential inapplicability, 
use of skip logic); for descriptive analyses, percentages were computed with the denominator 
being the number of responses for a specific item. All open-ended responses were coded, using 
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an interpretive-descriptive approach64–66. Google translate was used to translate non-English 
responses.  
To test objective 1, 2 and 3, LMICs were selected and descriptive statistics were used to 
summarize the closed-ended items (i.e., means and standard deviations, or n and percent).   
 To test objective 1(a), 2(a) and 3 (a), responses were then compared by economy 
classification (i.e., LMIC vs high-income country as defined by The World Bank; 
http://data.worldbank.org/country; independent variable). The nature of CR services and barriers 
were compared by country income classification and funding source via generalized linear mixed 
models where possible (treating country as a higher-order variable), otherwise bivariate analyses 
were computed (e.g., chi-square tests). 
 Finally, to test objective 1(b), 2(b), and 3(b), responses from LMICs were selected and 
compared by funding source terms of: capacity, components delivered, dose, health care 
professionals on the team, alternative models offered, diagnoses accepted and barriers to CR 
provision. This was undertaken through generalized linear mixed models (treating country as a 
higher-order variable) where possible.  
RESULTS 
As shown in Table 3 and Figure 1, 55/138 (39.9%) LMICs in the world were found to 
offer CR, of which data were collected in 47 (85.5% country response rate). Of these, two (of 5 
LICs with CR; 40.0%) were LICs, 15 (of 17; 88.2%) were lower-MICs and 30 (of 33; 90.9%) 
were upper-MICs. Overall, 335 (53.5% program response rate; shown by income classification 
in Table 3) surveys were initiated in LMICs, and 747 (27.2% response) in HICs. There was a 
mean of 6.1±13.3 (standard deviation; median=1) surveys per LMIC. Programs were mainly 
located in urban areas (n=300, 91.5%). 
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CR Availability, Volume, Capacity and Density in LMICs 
Availability of CR by country is shown in Figure 1 and Table 3. The year the first 
program was initiated in a LMIC in 1944 in Mexico, and 240 (77.4%) programs in LMICs 
opened since 2000 (of which 78 were in China). Worldwide, CR exists in 56 (86.2%) of the 67 
HICs (this is significantly greater than LMICs; Χ2=37.3, p<0.001), 49 (47.1%) of the 108 MICs, 
and in five (16.7%) of the 30 LICs. 
The number of programs per country is shown in Table 3. The median was 3 in LMICs 
and 15 in HICs (p<0.01). Including countries without CR, there was a median of zero 
programs/country in LICs, zero programs/country in MICs, and seven programs/country in HICs.  
In LMICs, median volume was 110 (Q25-Q75=50-300) patients per program; the median 
in HICs was 200 (Q25-Q75=120-395; Mann-Whitney U p<0.01).  
Programs in LMICs had the capacity to serve a median of 250 patients per program per 
year (Q25-Q75=100-481); the median in HICs was also 250 (Q25-Q75=183-44; p=0.70). 
Median national capacity in LICs with CR was 1,575 patients (to be interpreted with caution 
with only 2 responses), in lower-MICs was 200, in upper-MICs was 1,750 and HICs was 5,739 
per year. If we examine median national capacity across all countries of the globe (i.e., N=203; 
considering none in countries without CR), in LICs this would be zero patients, in MICs zero, 
and HICs 2,820 patients per year.   
National CR density is shown by country in Table 4 (in countries where CR exists; IHD 
incidence in countries without CR [i.e., no density] is also shown). Results showed wide 
variability across LMICs, with on average one spot per 52 incident IHD patients (308 in LICs, 
274 in lower-MICs and 30 in upper-MICs). Density was greatest in Georgia (one CR spot per 
two incident IHD patients) and lowest in Nigeria (one spot per 4,480). Median national density 
in HICs was one spot per five patients. The ranking of countries based on CR density is also 
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shown in Table 4 (lower scores reflective of better density); of 86 countries with data available, 
the mean rank for LICs was 66, and 61 for MICs. The top 25 countries were all HICs, except the 
following three MICs: Georgia (8th), Argentina (17th), and Colombia (22nd). Finally, including 
LMIC countries without CR, there was on average one CR spot per 66 incident IHD patients. 
Table 3 also displays unmet CR need. 
CR Indications Accepted  
Table 5 shows the accepted CR indications by country income classification. The three 
most commonly-accepted indications (acute coronary syndrome and revascularization patients) 
were consistent in LMICs and HICs, and with guidelines (HF ~90%). Valve procedures and 
heart transplant patients were significantly more likely to be accepted by programs in HICs than 
LMICs, and rheumatic heart disease was more-readily accepted in LMICs.  
Three-quarters of programs in LMICs accepted patients at high-risk of CVD or with 
diabetes as a primary indication (Table 5). Programs in LMICs were significantly more likely to 
accept these primary diagnoses, as well as patients with lung disease than programs in HICs. 
Other accepted indications reported by programs in LMICs were syncope (n=19, 29.2%), 
bariatric/obesity (n=16, 24.6%), and kidney disease (n=7, 10.8%) patients. 
CR Providers 
The most responsible clinician was some type of physician (e.g., cardiologist, physiatrist, 
sports medicine) in 254 (81.3%) LMIC programs, and in 428 (63.7%) HIC programs (X2=31.45, 
p=<0.001). The most commonly-present HCP type during exercise sessions was physiotherapists 
(n=185, 72.0%) in LMICs, and in HICs (n=392, 73.3%). The most common HCPs found on CR 
teams in LMICs were cardiologists, nurses, and physiotherapists; in HICs this was nurses, 
dietitians, and physiotherapists (Table 6). Two-thirds of programs had an administrative 
assistant, 57 (19.0%) some form of mental HCP, and one-fifth a community healthcare worker. 
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Other HCPs on the CR team were physicians of other specialties (n=14, 21.2%), other allied 
HCP (n=9, 13.6%), and generalist physicians (n=8, 12.1%). CR programs in LMICs were 
significantly more likely to have physicians on staff, whereas in HICs were significantly more 
likely to have nurses, dietitians, social workers, pharmacists, and administrative assistants on the 
CR team than LMICs.  Programs on average had six HCPs, with no significant difference by 
country income classification. 
CR Elements 
CR elements delivered are shown in Table 7 by country income classification. Initial 
assessment was the most frequently delivered core component (reflective of inclusion criteria), 
followed by management of cardiovascular risk factors and patient education in LMICs; this was 
similar in HICs. Eighty percent of programs offered supervised exercise training. Approximately 
two-thirds of programs had electronic charting. Initial functional capacity assessment was more 
commonly by a stress test in LMICs, in HICs other functional capacity tests, such as the 6-
minute walk test, were more common. Depression screening, nutrition counseling, stress 
management, tobacco cessation interventions, return-to-work counselling, and communication 
with the primary care provider were provided significantly more often by programs in HICs, 
with a significantly greater number of core components delivered in HICs than LMICs (although 
programs in LMICs more often offered “other” elements such as family education, and 
complementary/alternative medicine). Patients were significantly more likely to have an 
individual consult with a physician in LMICs but with a nurse in HICs. There was more follow-
up post-program in LMICs than HICs, and a trend towards more women-only classes (almost 
one in five programs).  
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CR Dose 
Table 8 shows the greater session frequency, and hence total number of sessions and 
overall “dose” in CR programs in LMICs and HICs. Median hours / program was 26.5 (Q25-
Q75=10-42) in LMICs.  
Alternate Models of CR Delivery 
Sixty-six (21.5%) programs in LMICs offered an alternative model of CR delivery than 
supervised clinic-based care, and 219 (36.0%) programs in HICs offered them (p<0.31). At a 
country level, of the 47 LMICs from which data were collected, 22 (46.8%) had at least one 
program that offered an alternative model (mean=22.7% of programs / country). Home-based 
programs were the most frequently offered alternative model in LMICs (n=40, 59.7%), followed 
by community-based (n=20, 29.9%), and hybrid programs (i.e., supervised transitioning to 
unsupervised; n=20, 29.9%). On average, alternative models were reimbursed by government or 
insurance in 9% of programs in LMICs, with the highest percentage of programs being 
reimbursed in Cuba (75.0%) 
Barriers to CR Delivery 
Respondents were asked to indicate what resources they would need in order to increase 
capacity for both home-based and community-based programs. Figure 2 summarizes their 
responses. Home-based programs more commonly required more equipment/ technology for 
communication while community based programs more commonly required more patient 
referral/ physician awareness. 
Table 9 displays program ratings of barriers to delivery of all models faced by CR 
programs in LMICs and HICs. The most highly-rated barriers in LMICs were lack of patient 
referral and financial resources, while financial and human resources were the greatest barriers in 
HICs. Patient referral was a significantly greater barrier in LMICs. Other barriers indicated by 
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programs in LMICs were lack of coverage / reimbursement for CR (n=25, 20.0%), transportation 
/ parking / distance (n=24; 19.2%), and lack of patient awareness (n=14; 11.2%).  
Costs and Sources of Funding for CR  
Respondents were requested to estimate the cost to treat one patient for a full program. 
Using purchasing power parity conversions (2016 USD)67, the median cost was $718.24 (Q25-
Q75=$337-1,232) in LMICs and $1,267 (Q25-Q75=$581-2,427) in HICs (Mann-Whitney U 
p<0.001).  
Figure 1 displays the most common source of funding for CR by country in LMICs. 
Funding sources in LMICs and HICs are summarized in Table 10 (respondents were instructed to 
select all that apply). Significantly more programs were funded by patients or private health 
insurance in LMICs than HICs, with more programs funded by clinical centres in HICs. Other 
sources of funding were also more common in HICs, which included research 
funding/universities, veteran programs, and charity foundations.  
As shown, patients were the most common CR payers in LMICs, paying some or all of the 
program cost (mean=49.3±38.4%) in 2/3rds of programs. Using purchasing power parity 
conversions67, the median cost to patients for a complete program when they paid was $338.29 
(Q25-Q75=$101-814) in LMICs and $244.86 (Q25-Q75=142-596) in HICS (p=0.72; not taking 
into consideration transportation costs or time off work).  
Tables 5-9 display CR program characteristics by funding source in LMICs. As shown in 
Table 5, there were no significant differences in cardiac indications accepted by funding source, 
but privately-funded programs were significantly more likely than public programs to accept 
high-risk primary prevention patients. As shown in Table 6, in terms of HCPs on staff, publicly-
funded programs had significantly more psychologists, pharmacists, and social workers, and 
privately-funded programs had more administrative assistants.  
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As shown in Table 7, privately-funded programs were significantly more likely than 
public programs to communicate with a patients’ primary care provider and offer resistance 
training, however they were least likely to offer tobacco cessation interventions. Public programs 
were significantly more likely than private programs to offer individual consults with a nurse and 
psychological counselling. There were no differences observed in total elements offered by 
funding source. 
As shown in Table 8, publicly-funded programs were of significantly longer duration 
than those funded by other means, resulting in significantly greater overall CR dose. Finally, as 
shown in Table 9, patient referral was a significantly greater barrier in privately-funded 
programs, while publicly-funded programs experienced significantly more human, space, and 
equipment barriers.  
DISCUSSION 
CR supply in LMICs is poor, with only ~40% of LMICs having any CR programs (with 
particularly low availability in LICs [only 5 programs globally, and hence results are primarily 
generalizable to MICs] and Africa [only 32 programs]). Where it is found, there is grossly 
insufficient capacity to meet the burden of disease. Available CR programs in MICs offer fewer 
core components; return-to-work counselling, stress management, and tobacco cessation 
interventions services should be offered more universally, particularly as they would be highly 
relevant to patients in LMICs. Programs in MICs had on average six staff, most commonly 
cardiologists, nurses, physiotherapists, and dietitians, offering on average 33 hours of CR to each 
patient over three months.  
Of the 92 countries globally without CR, over 90% are LMICs. Across all LMICs, 
14,766,930 more CR spots are needed annually to treat all incident IHD cases (vs only ~3.5 
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million needed across HICs), and even more spots would be needed to treat those with HF, 
among other indications. While IHD burden is still lower in LMICs than HICs, it is rapidly 
increasing. Clearly capacity needs to be increased. It was surprising that the programs that do 
exist were so comprehensive, and expensive (e.g., more use of stress tests, physicians), with a 
comparable staffing complement to HICs (i.e., number), as it was expected programs would be 
delivering the basics in an affordable manner so as to be feasible and reach as many patients as 
possible. This could be due to the methods of program identification in the study, or the 
motivation of profit given programs are more often privately-funded.  
CR programs in MICs accepted guideline-recommended indications11–13, including more 
recently HF14, but more often also accepted other non-communicable diseases. Whether this 
brings efficiency or drains capacity for cardiac patients warrants further investigation. In HICs, 
CR programs more-often treat patients after advanced cardiac procedures, likely because these 
procedures are more often performed in these settings.  
While there was a comparable number of staff on CR teams in HICs and MICs, the type 
of staff differed. Specifically, there was more physician contact in MICs. This could be due to 
lower labour costs in LMICs, or that it is cardiologists that have the capability/resources/position 
of opening programs in these settings. While some guidelines recommend physicians be a major 
part of CR team, not all do8,9. Task-shifting represents an important avenue to reduce the cost of 
CR delivery in LMICs. The International Council of Cardiovascular Prevention and 
Rehabilitation offers a certification program for teaching students, community healthcare 
workers and regulated HCPs alike how to deliver all core components in low-resource settings 
(http://globalcardiacrehab.com/training-opportunities/certification/).    
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Cost to deliver CR was significantly lower in MICs compared to HICs (consistent with 
most healthcare costs)68, yet still does not appear affordable when juxtaposed against healthcare 
expenditure per capita in LMICs which is $455.3969. Patients paid part of the cost of CR in two-
thirds of programs, with the median cost to patients being $338.29 USD PPP/program. Given the 
median annual income in LMICs is  $833 USD (2013 purchasing power parity)70, this is 
unaffordable. This would lead to physician failure to refer, which was the most common CR 
barrier in LMICs (as also reported in a recent review)18, as well as failure of patients to initiate 
CR or where they do, to dropout (such that although a higher dose of CR is prescribed in LMICs, 
patients are likely actually receiving a much lower dose). Indeed, patient or private funding 
sources were significantly more common in LMICs than HICs, consistent with the fact that there 
is more public funding of health systems in HICs than LMICs68. Funding source had an impact 
on indications accepted (non-cardiac), dose, as well as type (but not total number) of HCPs on 
staff, and components offered. Publicly-funded programs do appear to be of higher quality in 
terms of structure. Clearly, advocacy for public reimbursement is much needed71. 
Implications  
These results hold major implications for health policy. More programs are required to 
meet the growing need for CVD care in LMICs. The greatest barriers to CR delivery in LMICs 
were lack of referral (likely related to the dearth of programs to which patients can be referred), 
as well as lack of financial resources for both programs and patients. CR needs to be reimbursed 
to adequate levels to ensure delivery of all core components, by a reliable non-patient source. 
The cost-effectiveness of CR in LMICs has been demonstrated33, as has been the impacts in 
reducing downstream healthcare utilization costs72, and affordable CR models are established8,73. 
Given only one-fifth of programs offer alternative models (in only 22 of 136 LMICs), increasing 
home and community-based delivery may be an important means to increasing capacity, 
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particularly while exploiting information and communications technology74. Many LMICs 
already have established programs for communicable diseases, which could be re-purposed to 
deliver CR.     
Limitations 
These results should be interpreted with caution. First, some programs may not have been 
identified, especially in LICs where they may not have a website or published research, and in 
countries where no society or champion was identified. Therefore, availability, capacity, and 
density could be somewhat under-estimated. Moreover, due to our inclusion criteria and 
definition of CR (which stem from HICs), chronic disease management programs or clinics 
which are less comprehensive (e.g., no exercise) would not be represented. Second, though a 
high response rate at the country-level of 85% was achieved, response rates among programs 
within LMICs was just over 50%, and hence there may be some bias. However, the response rate 
is considered quite good for online surveys, and ultimately the sample was comprised of over 
half of CR programs in LMICs globally. 
Third, related to measurement, information on programs was reported by staff, and while 
responses were confidential, respondents may have responded in a manner that reflected what 
they know is recommended in guidelines (i.e., socially-desirable responding). So for example, 
the number of elements delivered may be higher than reality. Moreover, while the survey was 
pilot-tested, items were not validated through verification of responses in a random sub-sample 
of programs. The cost items in particular should be interpreted with caution. They were not 
sufficiently detailed to capture what types of costs respondents included in their estimates and 
how they were counted, and again were not validated against actual costs.  
Fourth, due to the nature of the design, causal or directional conclusions cannot be drawn. 
Finally, results of the study cannot be used to draw conclusions regarding whether the programs 
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as delivered improve patient outcomes, as that would require investigation of patient-level data. 
Only the structure and processes of programs were considered.   
CONCLUSION 
CR remains largely unavailable in the majority of LMICs. Where it exists, CR is quite 
consistent with guideline recommendations even from HICs, but is largely inaccessible to 
patients for reasons of capacity and finance. Increasing CR reimbursement, task-shifting, as well 
as offering more home-based programs could mitigate these barriers. 
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Figure 1: Most common cardiac rehabilitation funders in low- and middle-income countries* 
 
* Based on most frequent of the 3 funding sources. 
CR=cardiac rehabilitation  
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Figure 2: Resources required to increase alternative model delivery capacity in low- and middle-
income countries 
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Table 1: Low- and middle-income countries suspected or known to have cardiac rehabilitation 
(60/138) 
	
Country Country Income Classification* Region* 
Afghanistan Low-Income South Asia 
Algeria Upper-Middle-Income Middle East and North Africa 
Argentina Upper-Middle-Income Latin America and the Caribbean 
Belarus Upper-Middle-Income Europe and Central Asia 
Benin Low-Income Sub-Saharan Africa 
Bolivia Lower-Middle-Income Latin America and the Caribbean 
Brazil Upper-Middle-Income Latin America and the Caribbean 
Bulgaria Upper-Middle-Income Europe and Central Asia 
Cape Verde Lower-Middle-Income Sub-Saharan Africa 
China Upper-Middle-Income East Asia and Pacific 
Colombia Upper-Middle-Income Latin America and the Caribbean 
Costa Rica Upper-Middle-Income Latin America and the Caribbean 
Cuba Upper-Middle-Income Latin America and the Caribbean 
Dominican Republic Upper-Middle-Income Latin America and the Caribbean 
Ecuador Upper-Middle-Income Latin America and the Caribbean 
Egypt Lower-Middle-Income Middle East and North Africa 
El Salvador Lower-Middle-Income Latin America and the Caribbean 
Georgia Upper-Middle-Income Europe and Central Asia 
Grenada Upper-Middle-Income Latin America and the Caribbean 
Guatemala Lower-Middle-Income Latin America and the Caribbean 
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Honduras Lower-Middle-Income Latin America and the Caribbean 
India Lower-Middle-Income South Asia 
Indonesia Lower-Middle-Income East Asia and Pacific 
Iran, Islamic Republic Upper-Middle-Income Middle East and North Africa 
Iraq Upper-Middle-Income Middle East and North Africa 
Jamaica Upper-Middle-Income Latin America and the Caribbean 
Kazakhstan Upper-Middle-Income Europe and Central Asia 
Kenya Lower-Middle-Income Sub-Saharan Africa 
Korea, Democratic 
People's Republic 
Low-Income East Asia and Pacific 
Kyrgyz Republic Lower-Middle-Income Europe and Central Asia 
Lebanon Upper-Middle-Income Middle East and North Africa 
Macedonia Upper-Middle-Income Europe and Central Asia 
Malaysia Upper-Middle-Income East Asia and Pacific 
Maldives Upper-Middle-Income South Asia 
Mexico Upper-Middle-Income Latin America and the Caribbean 
Moldova Lower-Middle-Income Europe and Central Asia 
Morocco Lower-Middle-Income Middle East and North Africa 
Nepal Low-Income South Asia 
Nicaragua Lower-Middle-Income Latin America and the Caribbean 
Nigeria Lower-Middle-Income Sub-Saharan Africa 
Pakistan Lower-Middle-Income South Asia 
Panama Upper-Middle-Income Latin America and the Caribbean 
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Paraguay Upper-Middle-Income Latin America and the Caribbean 
Peru Upper-Middle-Income Latin America and the Caribbean 
Philippines Lower-Middle-Income East Asia and Pacific 
Romania Upper-Middle-Income Europe and Central Asia 
Russian Federation Upper-Middle-Income Europe and Central Asia 
Rwanda Low-Income Sub-Saharan Africa 
Serbia Upper-Middle-Income Europe and Central Asia 
South Africa Upper-Middle-Income Sub-Saharan Africa 
Sri Lanka Lower-Middle-Income South Asia 
Tanzania Low-Income Sub-Saharan Africa 
Thailand Upper-Middle-Income East Asia and Pacific 
Tunisia Lower-Middle-Income Middle East and North Africa 
Turkey Upper-Middle-Income Europe and Central Asia 
Uganda Low-Income Sub-Saharan Africa 
Ukraine Lower-Middle-Income Europe and Central Asia 
Venezuela Upper-Middle-Income Latin America and the Caribbean 
*Based on World Bank classifications29
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Table 2: Summary of Findings – Results from Review of National/Regional Surveys of Cardiac 
Rehabilitation Programs in LMICs, N=4 
 
Region Results 
Country 
(year of 
publicati
on) 
Numb
er of 
Respo
ndent
s/Cent
ers 
(respo
nse 
rate 
%) 
Dose§ 
(weeks 
x 
frequen
cy/wee
k) 
Staff 
Compositi
on 
Reimburse
ment 
Source 
Compon
ents 
Delivere
d 
Barriers 
Patient
s 
Served  
progra
m or 
countr
y 
(pts 
served/ 
yr) 
 
Patient 
diagnose
s 
accepted 
Alternate 
Models 
(% yes) 
Eastern Asia and Pacific 
China 
(2016)59 
10/ - - 
Physicians 
(100%) 
Nurses 
(85%) 
Dietitians 
(46%) 
 
- 
IA 
(100%) 
PE 
(100%) 
NC 
(100%) 
 
Lack of 
interest 
(58%) 
Lack of 
human 
resources 
(58%) 
Lack of 
awareness 
- 
PCI 
(100%) 
HF 
(100%) 
MI 
(92%) 
 
- 
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(50%) 
Latin America and the Caribbean 
Latin 
America 
and the 
Caribbea
n 
(2009)19 
33/ - 
33 
(13 x 
2.5) 
Cardiologi
sts (100%) 
Physical 
therapists 
(94%) 
Dietitians 
(91%) 
Hospital 
(24%) 
Social 
security 
(24%) 
Private 
Insurance 
(24%) 
- 
Lack of 
trained 
personnel 
(41%) 
Lack of 
finances 
(33%) 
 
<2000 
(81%) 
MI 
(100%) 
PCI 
(97%) 
CABG 
(97%) 
CB 
(48%)  
 
South 
America 
(2013)20 
107/ - - 
Cardiologi
sts (85%) 
Nutritionis
ts (72%) 
Physical 
therapists 
(72%) 
Mixed 
(46%) 
Private 
Insurance 
(19% 
Patient 
(18%) 
ET 
(97%) 
RF 
(96%) 
NC 
(91%) 
Lack of 
economic 
resources 
(13%) 
Lack of 
space (6%) 
 
180 
MI 
(100%) 
PCI 
(99%) 
CABG 
(97%) 
- 
Mexico 
(2016)57 
24/24 
(100
%) 
- 
Physicians 
(100%) 
Administra
tive 
assistants 
(100%) 
- 
ET 
(100%) 
NC 
(90%) 
SM 
(80%) 
Lack of 
finances 
(83%) 
Lack of 
trained 
personnel 
- 
IHD 
(100%) 
PCI 
(100%) 
HF 
(92%) 
HB 
(37.5%) 
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Physiother
apists 
(83%) 
(67%) 
Deficient 
equipment 
(46%) 
§ if only a range was provided, the midpoint of ranges is reported; if multiple ranges reported, 
the one with the highest percentage was used 
(-) Article did not report 
CABG = coronary artery bypass graft; CB = community based; CR = cardiac rehabilitation; ET 
= Exercise training; ETS = Exercise testing; HB = home based; HF = Heart failure; IA = Initial 
assessment; IHD = ischemic heart disease; LMIC = low- and middle-income countries; MI = 
Myocardial infarction; NC = nutrition counseling; PCI = percutaneous coronary intervention; RF 
= Risk factor management; SM = stress management 
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Table 3. Availability of Cardiac Rehabilitation Programs in Low- and Middle-Income Countries, 
Response Rate, and Unmet Need 
Income Classification 
Country 
Number of 
Responses 
Number of 
Programs 
Response 
Rate 
Unmet 
CR 
Need* 
Upper Middle-Income 
Albania 0 0 - 9,490 
Algeria 1 1 100.0% - 
Argentina 3 23 13.0% 76,357 
Azerbaijan 0 0 - 28,593 
Belarus 1 5 20.0% 87,374 
Belize 0 0 - 596 
Bosnia and Herzegovina 1 1 100.0% 17,068 
Botswana 0 0 - 3,569 
Brazil 30 75 40.0% 523,662 
Bulgaria 1 1 100.0% 52,871 
China 83 216 37.5% 3,034,003 
Colombia 48 50 96.0% 55,745 
Costa Rica 6 6 100.0% 7,568 
Cuba 8 8 100.0% 48,349 
Dominica 0 0 - 209 
Dominican Republic 1 2 50.0% 193,919 
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Ecuador 2 5 40.0% 26,096 
Equatorial Guinea 0 0 - 1,105 
Fiji 0 0 - 1,631 
Gabon 0 0 - 2,272 
Georgia 13 17 76.5% 6,288 
Grenada 0 1 0.0% - 
Guyana 0 0 - 1,814 
Iran 14 34 41.2% 219,007 
Iraq 0 0 - 117,130 
Jamaica 1 3 33.3% 7,846 
Kazakhstan 1 1 100.0% 57,125 
Lebanon 1 1 100.0% 27,333 
Libya 0 0 - 20,254 
Macedonia, FYR 1 1 100.0% 8,285 
Malaysia 4 6 66.7% 84,724 
Maldives 0 0 - 625 
Marshall Islands 0 0 - 98 
Mauritius 1 1 100.0% 107,880 
Mexico 9 24 37.5% 155,348 
Montenegro 0 1 0.0% 2,964 
Nambia 0 0 - 3,412 
Nauru 0 0 - - 
Panama 1 1 100.0% 4,959 
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Paraguay 3 3 100.0% 14,292 
Peru 7 10 70.0% 47,467 
Romania 2 3 66.7% 119,335 
Russia 3 - - 1,222,142 
Saint Lucia 0 0 - 288 
Saint Vincent and Grenadines 0 0 - 296 
Samoa 0 0 - 299 
Serbia 2 2 100.0% 37,125 
South Africa 14 23 60.8% 107,880 
Suriname 0 0 - 1,468 
Thailand 0 5 0.0% - 
Tonga 0 0 - 168 
Turkey 9 10 90.0% 334,117 
Turkmenistan 0 0 - 9,388 
Tuvalu 0 0 - - 
Venezuela 8 9 88.9% 44,108 
Program response rate in 
upper-MICs  
(30/33 countries with CR; 
90.9% country response rate) 
279 549 50.3% - 
Total Unmet Need in Upper- 
MICs  
- - - 6,933,942 
Lower Middle-Income 
Angola 0 0 - 24,579 
Armenia 0 0 - 11,125 
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Bangladesh 1 1 100.0% 409,010 
Bhutan 0 0 - 1,319 
Bolivia 0 0 - 19,423 
Cambodia 0 0 - 22,764 
Cameroon 0 0 - 25,761 
Cape Verde 0 0 - 965 
Congo 0 0 - 5,921 
Cote d’Ivoire 0 0 - 31,106 
Djibouti 0 0 - 1,407 
Egypt 2 2 100.0% 369,288 
El Salvador 0 2 0.0% - 
Federated States of Micronesia 0 0 - 147 
Ghana 0 0 - 36,001 
Guatemala 2 2 100.0% 13,551 
Honduras 1 2 50.0% 10,899 
India 18 23 78.3% 3,304,474 
Indonesia 10 13 76.9% 65,376 
Jordan 0 0 - 22,639 
Kenya 1 3 33.3% 55,114 
Kiribati 0 0 - 162 
Kosovo 0 0 - - 
Kyrgyzstan  0 1 0.0% - 
	 45	
Laos 0 0 - 10,390 
Lesotho 0 0 - 2,997 
Mauritania 0 0 - 5,612 
Moldova 1 1 100.0% 20,976 
Mongolia 1 1 100.0% 5,241 
Morocco 1 1 100.0% 156,088 
Myanmar 0 0 - 108,283 
Nicaragua 0 0 - 7,341 
Nigeria 1 1 100.0% 223,944 
Pakistan 2 4 50.0% 616,146 
Palestine 0 0 - - 
Papua New Guinea 0 0 - 11,091 
Philippines 10 10 100.0% 211,507 
Sao Tome and Principe 0 0 - 263 
Solomon Islands 0 0 - 753 
Sri Lanka 2 4 50.0% 66,507 
Sudan 0 0 - 111,063 
Swaziland 0 0 - 1,925 
Syria 0 0 - 57,355 
Tajikistan 0 0 - 13,029 
Timor-Leste 0 0 - 1,695 
Tunisia 1 1 100.0% 50,067 
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Ukraine 0 0 - 519,761 
Uzbekistan 0 0 - 90,959 
Vanuatu 0 0 - 399 
Vietnam 0 0 - 238,156 
Yemen 0 0 - 69,006 
Zambia 0 0 - 18,951 
Program response rate in 
lower-MICs  
(15/17 countries with CR; 
88.2% country response rate) 
54 72 75.0% - 
Total Unmet Need in Lower- 
MICs  
- - - 7,050,536 
Low Income 
Afghanistan  1 1 100.0% 88,906 
Benin 0 1 0.0% - 
Burkina Faso 0 0 - 19,241 
Burundi 0 0 - 13,432 
Central African Republic 0 0 - 6,831 
Chad 0 0 - 16,436 
Comoros 0 0 - 1,034 
Democratic Republic of the 
Congo 
0 0 - 82,818 
Eritrea 0 0 - 5,386 
Ethiopia 0 0 - 138,477 
Gambia 0 0 - 2,607 
Guinea 0 0 - 16,645 
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Guinea-Bissau 0 0 - 2,797 
Haiti 0 0 - 23,896 
Liberia 0 0 - 6,669 
Madagascar 0 0 - 32,640 
Malawi 0 0 - 25,374 
Mali 0 0 - 17,278 
Mozambique 0 0 - 41,012 
Nepal 1 1 100.0% 63,134 
Niger 0 0 - 23,462 
North Korea 0 0 - 48,117 
Rwanda 0 0 - 11,947 
Senegal 0 0 - 20,843 
Sierra Leone 0 0 - 9,247 
Somalia 0 0 - 15,179 
South Sudan 0 0 - 17,290 
Tanzania 0 1 0.0% - 
Togo 0 0 - 9,988 
Uganda 0 1 0.0% - 
Zimbabwe 0 0 - 21,766 
Program response rate in LICs 
(2/5 countries with CR; 40.0% 
country response rate) 
2 5 40.0% - 
Total Unmet Need in LICs  - - - 782,452 
LMIC Program Response Rate 
(47/55 LMICs with CR; 85.5% 
335 626 53.5% - 
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country response rate) 
Total Unmet Need in all LMICs - - - 14,766,930 
LMICs, low- and middle-income countries; CR, cardiac rehabilitation  
-not applicable/missing 
*number of annual incident ischemic heart disease cases estimated in Global Burden of Disease 
study63 minus national annual CR capacity, to reflect total number more CR spots needed per 
year.  
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Table 4: Cardiac Rehabilitation Availability, Volume, Capacity, and Density by Country with 
Any Cardiac Rehabilitation, N=111 
Country 
IHD 
incidenc
e† 
Year 
1st CR 
progra
m 
# CR 
progra
ms in 
country 
Media
n 
annual 
volume
/ 
progra
m 
Media
n 
annual 
capacit
y / 
progra
m 
National 
CR 
capacity‡  
CR 
densit
y§ 
CR 
densit
y 
ranki
ng || 
Low- and Middle-Income 
Afghanist
an 89,056 2014 1 100 150 150 594 82 
Algeria 140,592 NA 1 NA NA NA  NA NA 
Argentina 122,357 1998 23 1,500 2,000 46,000 3 17 
Banglades
h 409,210 NA 1 160 200 200 2,046 85 
Belarus 88,874 1981 5 300 300 1,500 59 68 
Benin 11,973 NA 1 NA  NA NA NA NA 
Bosnia 
and 
Herzegovi
na 
19,068 1959 1 800 2,000 2,000 10 35 
Brazil 529,062 1973 75 60 72 5,400 98 73 
Bulgaria 55,871 1958 1 2,200 3,000 3,000 19 46 
China 3,104,203 1984 216 300 325 70,200 44 63 
Colombia 75,245 1972 50 410 390 19,500 4 22 
Costa 
Rica 8,288 1985 6 45 120 720 12 38 
Cuba 49,789 1973 8 145 180 1,440 35 57 
Dominica
n 
Republic 
193,919 2016 2 NA  NA NA NA NA 
Ecuador 27,046 1995 5 36 190 950 29 55 
Egypt 369,488 2010 2 20 100 200 1,847 84 
El 
Salvador 9,129 NA 2 NA NA NA NA NA 
FYR of 
Macedoni
a 
8,285 NA 1 NA NA NA NA NA 
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Georgia 16,488 1994 17 180 600 10,200 2 8 
Grenada 296 NA 1 NA NA NA NA NA 
Guatemal
a 13,671 2011 2 18 60 120 114 75 
Honduras 10,939 2005 2 20 20 40 274 78 
India 3,313,674 1997 23 200 400 9,200 360 80 
Indonesia 66,676 1985 13 98 100 1,300 51 64 
Iran 235,157 1994 34 250 475 16,150 15 41 
Jamaica 8,026 2006 3 24 60 180 45 62 
Kazakhsta
n 57,125 NA 1 NA NA NA NA NA 
Kenya 55,174 2010 3 20 50 150 368 81 
Kyrgyz 
Republic 11,398 NA 1 NA NA NA NA NA 
Lebanon 27,633 2014 1 100 300 300 92 71 
Malaysia 86,224 2007 6 300 250 1,500 58 67 
Mauritius 3,872 2013 1 60 60 60 65 70 
Mexico 161,348 1944 24 38 250 6,000 27 54 
Moldova 21,376 2016 1 200 400 400 53 66 
Mongolia 5,241 2013 1 NA NA NA NA NA 
Monteneg
ro 3,049 NA 1 NA NA NA NA NA 
Morocco 156,088 2016 1 NA NA NA NA NA 
Nepal 66,134 2008 1 2,000 3,000 3,000 22 50 
Nigeria 223,994 2012 1 50 50 50 4,480 86 
Pakistan 622,146 2004 4 900 1,500 6,000 104 74 
Panama 5,039 2006 1 38 80 80 63 69 
Paraguay 14,892 2011 3 125 200 600 25 53 
Peru 49,967 1992 10 80 250 2,500 20 47 
Philippine
s 217,107 1975 10 105 560 5,600 39 61 
Romania 126,835 1978 3 1,400 2,500 7,500 17 44 
Russia 1,223,642 2010 3 400 500 1,500 816 83 
Serbia 40,265 1968 2 1,345 1,570 3,140 13 39 
South 
Africa 108,455 1989 23 50 90 2,070 52 65 
South 
Korea 94,661 2009 17 200 250 4,250 22 51 
Sri Lanka 66,927 2012 4 114 105 420 159 77 
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Tanzania 64,326 NA 1 NA NA NA NA NA 
Thailand 199,828 NA 5 NA NA NA NA NA 
Tunisia 50,217 2010 1 90 150 150 335 79 
Turkey 337,617 2010 10 100 350 3,500 97 72 
Uganda 31,951 NA 1 NA NA NA NA NA 
Venezuela 45,575 1974 9 103 163 1,467 31 56 
Mean ± 
SD 
234,902
± 
610,998 
1996±1
9 12±31 
350±54
5 
556±80
5 
5,683±12,8
73 
300±7
88 61±19 
Median 
(IQR) 
60,726 
(15,291-
160,033) 
2005 
(1982-
2011) 
3 (1-10) 
110 
(50-
300) 
250 
(100-
481) 
1,500 (200-
5,450) 
52 (22-
125) 
65 
(49-
76) 
High-Income 
Aruba NA NA 1 NA NA NA NA NA 
Australia 80,169 1970 314 200 200 62,800 1 5 
Austria 32,901 1962 26 750 200 5,200 6 31 
Bahrain 3,842 1998 1 140 500 500 8 33 
Barbados 1,240 1994 1 70 96 96 13 40 
Belgium 66,985 1977 48 275 300 14,400 5 27 
Bermuda 197 2012 1 220 400 400 1 1 
Brunei 471 2004 2 55 80 160 3 19 
Canada 91,030 1960 170 300 300 51,000 2 9 
Chile 45,008 2009 10 30 200 2,000 23 52 
Croatia 26,066 1957 3 940 940 2,820 9 34 
Curaçao  NA NA 2 120 200 400 NA NA 
Cyprus 2,665 NA 1 NA NA NA NA NA 
Czech 
Republic 66,012 1993 15 65 200 3,000 22 49 
Denmark 23,455 1990 35 200 250 8,750 3 18 
England 318,284 1978 266 490 500 133,000 2 14 
Estonia 10,938 1994 2 150 150 300 37 58 
Finland 25,677 1978 25 55 98 2,450 11 36 
France 259,251 1984 130 475 485 63,050 4 24 
Germany 385,474 1950 120 800 825 99,000 4 23 
Greece 61,036 1993 4 20 100 400 153 76 
Guam 311 NA 1 NA NA NA NA NA 
Hungary 69,698 1970 33 440 580 19,140 4 21 
Iceland 1,570 1983 4 168 185 740 2 10 
Ireland 16,000 1985 37 256 300 11,100 1 6 
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Israel 23,152 1964 22 1,000 1,000 22,000 1 4 
Italy 359,226 1974 221 350 355 78,455 5 26 
Japan 501,740 1990 325 150 300 97,500 5 30 
Kuwait 7,648 NA 1 NA NA NA NA NA 
Latvia 14,743 1997 2 150 400 800 18 45 
Lithuania 23,421 1977 25 950 1,000 25,000 1 3 
Luxembo
urg 1,683 NA 4 NA NA NA NA NA 
Malta 1,958 2012 1 300 900 900 2 11 
Netherlan
ds 88,550 1974 90 555 450 40,500 2 12 
New 
Zealand 10,110 1968 43 200 146 6,278 2 7 
Northern 
Ireland 8,811 1980 13 255 215 2,795 3 20 
Norway 15,197 NA 35 NA NA NA NA NA 
Poland 237,460 1973 56 350 375 21,000 11 37 
Portugal 35,884 1988 23 75 100 2,300 16 42 
Puerto 
Rico 15,286 NA 1 NA NA NA NA NA 
Qatar 7,003 2013 1 157 192 192 37 59 
Saudi 
Arabia 82,510 NA 1 NA NA NA NA NA 
Scotland 30,185 1985 69 1,025 850 58,650 1 2 
Singapore 14,299 1979 7 260 438 3,066 5 28 
Slovak 
Republic 29,436 2015 7 50 200 1,400 21 48 
Slovenia 11,135 1995 2 100 150 300 37 60 
Spain 175,537 1993 87 120 120 10,440 17 43 
Sweden 50,475 NA 69 150 150 10,350 5 29 
Switzerlan
d 29,546 1997 51 255 255 13,005 2 13 
Taiwan 43,795 1978 35 70 180 6,300 7 32 
Trinidad 
and 
Tobago 
4,759 NA 2 NA NA NA NA NA 
United 
Arab 
Emirates 
21,885 NA 1 NA NA NA NA NA 
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United 
States of 
America 
1,344,97
4 1970 2,632 150 208 547,456 3 16 
Uruguay 10,656 1970 12 120 200 2,400 4 25 
Wales 15,432 1986 17 490 375 6,375 2  15 
Mean ± 
SD 
90,656± 
206,728 
1984±1
6 93±357 
300±27
8 
348±25
9 
31,959±84,
666 12±24 27±18 
Median 
(IQR) 
23,455 
(9,461-
68,341) 
1984 
(1973-
1994) 
15 (2-
51) 
200 
(120-
395) 
250 
(183-
444) 
6,278 (850-
23,500) 
5 (2-
13) 
26 
(12-
40) 
Global 
Mean ± 
SD 
164,764 
± 
464,692 
1990 ± 
18 
52 ± 
254 
324 ± 
426 
448 ± 
595 
19,237 ± 
62,588 
153 ± 
566 
44 ± 
25 
Global 
Median  
(IQR) 
40,265 
(11,267-
101,558) 
1992 
(1975-
2009) 
4 (1-25) 
157 
(75-
350) 
250 
(150-
450) 
2,795 (420-
10,440) 
17 (4-
53) 
44 
(23-
66) 
†Incidence of IHD was obtained from Global Burden of Disease study63 
‡National CR capacity calculated using median number of patients program could serve per year 
(from survey) multiplied by the number of programs in the country (ascertained from national 
champions)· Value represents the number of patients who could receive CR in a year (i.e., CR 
spots). 
§CR density refers to the number of incident IHD cases per year per CR spot (i.e, national CR 
capacity). 
||Ranking based on density, or ratio of need (i.e., IHD incidence) to supply (i.e., national CR 
capacity). Lower numbers reflect more CR spots per IHD patient (i.e., of 86 countries where CR 
and sufficient information are available such that 1 represents the most spots per IHD patient and 
86 is the least spots per patient). 
Acronyms: LIC, Low-income country; LMI, lower middle-income; UMI, Upper middle-income; 
HIC, high-income country; IHD, ischemic heart diseases; CR cardiac rehabilitation; NA, not 
available; SD, standard deviation; IQR: interquartile range; WHO, World Health Organization. 
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Table 5. Accepted Cardiac Rehabilitation Indications by Country Income Classification and 
Funding Source, N=1082 
 LMIC 
HIC 
(n=747) 
p* 
 
Private 
(n=103) 
Public 
(n=115
) 
Hybrid 
(n=108) 
Total† 
(n=326)ǁ 
  
Cardiac       
Myocardial 
Infarction/ Acute 
Coronary 
Syndrome 
100 
(97.1%) 
78 
(95.1
%) 
90 
(90.68%) 
268 
(96.4%) 
562 
(97.9%) 
0.52 
PCI 94 
(91.3%) 
78 
(95.1
%) 
91 
(97.8%) 
263 
(94.6%) 
554 
(96.9%) 
0.34 
CABG 
98 
(95.1%) 
78 
(95.1
%) 
87 
(93.5%) 
263 
(94.6%) 
551 
(96.3%) 
0.83 
Stable coronary 
artery disease, 
without a recent 
event or 
procedure 
94 
(91.3%) 
72 
(87.8
%) 
87 
(93.5%) 
253 
(91.0%) 
437 
(76.4%) 
0.06 
Heart failure 
88 
(85.4%) 
68 
(82.9
%) 
87 
(93.5%) 
243 
(87.4%) 
511 
(89.3%) 
0.25 
Valve procedure 80 61 71 212 522 <0.01 
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(77.7%) (74.4
%) 
(76.3%) (76.3%) (91.3%) 
Rhythm device 
75 
(72.8%) 
60 
(73.2
%) 
73 
(78.5%) 
208 
(74.8%) 
454 
(79.4%) 
0.16 
Arrhythmias 
76 
(73.8%) 
55 
(67.1
%) 
75 
(80.6%) 
206 
(74.1%) 
358 
(62.6%) 
0.49 
Cardiomyopathy 
75 
(72.8%) 
56 
(68.3
%) 
73 
(78.5%) 
204 
(73.4%) 
437 
(76.4%) 
0.27 
Congenital heart 
disease 
64 
(62.1%) 
46 
(56.1
%) 
66 
(71.0%) 
176 
(63.3%) 
316 
(55.2%) 
0.39 
Rheumatic heart 
disease 
61 
(59.2%) 
53 
(64.6
%) 
62 
(66.7%) 
176 
(63.3%) 
258 
(45.1%) 
<0.05 
Ventricular assist 
devices 
42 
(40.8%) 
38 
(46.3
%) 
54 
(58.1%) 
134 
(48.2%) 
304 
(53.1%) 
0.24 
Heart transplant 
43 
(41.7%) 
28 
(34.1
%) 
36 
(38.7%) 
107 
(38.5%) 
363 
(63.5%) 
<0.00
1 
Non-cardiac       
High-risk / 
primary 
prevention 
87 
(84.5%) 
ǂ 
50 
(61.0
%) 
70 
(75.3%) 
207 
(74.5%)† 
283 
(49.5%) 
<0.01 
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ǂ 
Diabetes 
85 
(82.5%) 
52 
(63.4
%) 
66 
(71.0%) 
203 
(73.0%) 
215 
(37.6%) 
<0.00
1 
Intermittent 
claudication/ 
peripheral 
vascular disease 
68 
(66.0%) 
44 
(53.7
%) 
59 
(63.4%) 
171 
(61.5%) 
250 
(43.7%) 
0.06 
Chronic lung 
disease 
66 
(64.1%) 
34 
(41.5
%) 
56 
(60.2%) 
156 
(56.1%) 
183 
(32.0%) 
<0.01 
Stroke / transient 
ischemic attack 
40 
(38.8%) 
32 
(39.0
%) 
31 
(33.3%) 
103 
(37.1%) 
150 
(26.2%) 
0.24 
Cancer 
35 
(34.0%) 
13 
(15.9
%) 
24 
(25.8%) 
72 
(25.9%) 
91 
(15.9%) 
0.18 
*Generalized Linear Mixed Models were used to test for significant differences in LMICs versus 
HICs. 
†p< 0.05 for Generalized Linear Mixed Models testing for significant differences by most 
common funding source;  
For pairwise comparisons ǂ=p<0.01 
ǁrespondents did not provide information on funding source for CR in 9/335 surveys 
CABG=Coronary artery bypass graft; HIC=high-income country; LMIC= low- and middle-
income country; PCI=percutaneous coronary intervention.  
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Table 6: Healthcare Professionals on Cardiac Rehabilitation Staff by Country Income 
Classification and Funding Source, N=1082 
 LMIC 
HIC 
(n=747) 
p* 
 
Private 
(n=103) 
Public 
(n=115) 
Hybrid 
(n=108) 
Total† 
(n=326)ǁ 
  
Cardiologist 
91 
(88.3%) 
88 
(92.6%) 
87 
(87.0%) 
266 
(89.3%) 
453 
(72.5%) 
<0.001 
Nurse 
65 
(65.0%) 
79 
(84.0%) 
90 
(90.0%) 
234 
(79.6%) 
544 
(91.7%) 
<0.001 
Physiotherapist 
83 
(81.4%) 
73 
(78.5%) 
77 
(76.2%) 
233 
(78.7%) 
500 
(79.9%) 
0.60 
Dietitian 
82 
(80.4%) 
70 
(75.3%) 
67 
(68.4%) 
219 
(74.7%) 
520 
(83.2%) 
0.001 
Administrative 
assistant / 
secretary 
69 
(68.3%)ǂ 
56 
(60.9%) 
54 
(55.1%)ǂ 
179 
(61.5%)† 
417 
(67.9%) 
<0.05 
Psychologist 
50 
(48.5%) 
65 
(69.9%)¶ 
53 
(54.1%) 
168 
(57.1%)† 
357 
(58.0%) 
0.69 
Physiatrist / 
PM&R 
42 
(44.7%) 
60 
(63.2%) 
51 
(53.7%) 
153 
(53.9%) 
235 
(38.5%) 
<0.001 
Kinesiologist / 
Exercise specialist 
61 
(58.7%) 
47 
(50.5%) 
 
45 
(46.9%) 
153 
(52.2%) 
310 
(52.1%) 
0.71 
Other physician 
43 
(45.7%) 
42 
(46.7%)  
32 
(34.8%) 
117 
(42.4%) 
215 
(36.1%) 
0.08 
Sports medicine 42 23 38 103 80 <0.001 
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physician (42.9%) (25.3%) (38.8%) (36.1%) (13.3%) 
Psychiatrist 
33 
(34.7%) 
39 
(42.9%) 
27 
(28.7%) 
99 
(35.4%) 
107 
(17.8%) 
<0.001 
Pharmacist 
14 
(14.6%)ǂǂ 
41 
(46.1%)ǂǂ 
36 
(37.9%) 
91 
(32.5%)†† 
275 
(45.1%) 
0.001 
Social worker 
16 
(16.7%)ǂǂ 
39 
(42.4%)ǂǂ 
25 
(26.3%) 
80 
(28.3%)†† 
300 
(48.8%) 
<0.001 
Community 
health worker 
12 
(12.8%) 
24 
(26.1%) 
23 
(24.5%) 
59 
(21.1%) 
109 
(18.0%) 
0.28 
Other 
12 
(21.8%) 
18 
(28.1%) 
19 
(25.7%) 
49 
(25.4%) 
122 
(39.0%) 
0.001 
Total # of 
program staff§ 
5.4 ± 2.5 6.3 ± 3.2 5.8 ± 2.8 5.8 ±2.8  5.9 ± 2.8 0.58 
ǁrespondents did not provide information on funding source for CR in 9/335 surveys.  
*Generalized Linear Mixed Models could not reliable be used to test for significant differences 
in LMICs versus HICs so Pearson’s chi-square were computed. 
† p< 0.05;  †† p< 0.01; ††† p< 0.001 for Generalized Linear Mixed Models testing for 
significant differences by most common funding source;  
For pairwise comparisons ǂ: one symbol=p<0.05; two symbols=p<0.01; 3 symbols=p<0.001 
¶Significantly different from all funding sources (p<0.01). 
HIC=high-income country; LMIC= low- and middle-income country 
§frequency and percent of personnel on team, with full-time personnel counted as 1 and part-
time personnel counted as 0.50. 
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Table 7: Cardiac Rehabilitation Elements Delivered by Country Income Classification and 
Funding Source, N=1082 
n (%) LMIC 
HIC 
(n=747) 
p* 
 
Private 
(n=103) 
Public 
(n=115) 
Hybrid 
(n=108) 
Total† 
(n=326)ǂ 
  
Core Components       
Initial Assessment 
105 
(99.1%) 
96 
(100.0%) 
101 
(99.0%) 
305 
(99.0%) 
634 
(98.8%) 
0.91 
Management of CV 
Risk Factors 
103 
(97.2%) 
94 
(97.9%) 
101 
(99.0%) 
298 
(98.0%) 
627 
(98.4%) 
0.75 
Patient Education 
87 
(96.7%) 
87 
(91.6%) 
93 
(96.9%) 
267 
(95.0%) 
591 
(97.7%) 
0.39 
End of program re-
assessment 
99 
(93.4%) 
86 
(91.5%) 
87 
(87.9%) 
272 
(91.0%) 
584 
(91.8%) 
0.74 
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Prescription and/or 
titration of medications 
88 
(82.2%) 
89 
(92.7%) 
95 
(93.1%) 
272 
(89.2%) 
476 
(74.6%) 
0.13 
Supervised Exercise 
Training 
92 
(86.0%) 
71 
(75.5%) 
79 
(78.2%) 
242 
(80.1%) 
530 
(82.8%) 
0.83 
Communication of 
assessment results to 
patients’ primary care 
provider 
88 
(82.2%)◊ 
58 
(61.1%)◊ 
78 
(77.2%) 
224 
(73.9%)† 
562 
(89.1%) 
<0.01 
Stress Management 
73 
(68.9%) 
66 
(70.2%) 
73 
(72.3%) 
212 
(70.4%) 
556 
(87.0%) 
<0.01 
Tobacco cessation 
interventions 
sessions/classes 
50 
(47.6%)¶ 
72 
(75.0%) 
67 
(67.0%) 
189 
(62.8%)††† 
500 
(78.2%) 
0.001 
Return-to-work 
counselling 
58 
(55.8%) 
62 
(66.0%) 
62 
(62.0%) 
182 
(61.1%) 
431 
(68.2%) 
<0.05 
Other Elements       
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Heart rate 
measurement training / 
exercise intensity 
monitoring 
104 
(98.1%) 
93 
(96.9%) 
101 
(99.0%) 
298 
(98.0%) 
587 
(92.3%) 
0.13 
Individual consult with 
a physician 
98 
(92.5%) 
89 
(94.7%) 
95 
(94.1%) 
282 
(93.7%) 
412 
(64.4%) 
<0.05 
Assessment of 
Comorbidities 
95 
(91.3%) 
86 
(90.5%) 
88 
(88.0%) 
269 
(90.0%) 
605 
(94.7%) 
0.10 
Resistance Training 
102 
(95.3%)◊◊ 
76 
(80.9%)◊◊ 
92 
(90.2%) 
270 
(89.1%)† 
585 
(91.7%) 
0.17 
Nutrition Counseling 
91 
(85.0%) 
85 
(88.5%) 
92 
(90.2%) 
268 
(87.9%) 
609 
(95.2%) 
<0.05 
Exercise Prescription 
98 
(91.6%) 
83 
(87.4%) 
85 
(84.2%) 
266 
(87.8%) 
566 
(88.6%) 
0.55 
Physical Activity 
Counseling 
96 
(90.6%) 
82 
(86.3%) 
86 
(86.0%) 
264 
(87.7%) 
582 
(90.7%) 
0.89 
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Exercise Stress Test 
91 
(85.8%) 
83 
(89.2%) 
76 
(76.8%) 
250 
(83.9%) 
403 
(63.5%) 
<0.001 
Follow-up post-
program 
87 
(82.1%) 
80 
(84.2%) 
75 
(74.3%) 
242 
(80.1%) 
418 
(65.9%) 
<0.01 
Depression screening 
79 
(74.5%) 
72 
(75.0%) 
83 
(82.2%) 
234 
(77.2%) 
579 
(90.6%) 
<0.01 
Other Functional 
Capacity Test 
82 
(78.8%) 
72 
(76.6%) 
72 
(72.7%) 
226 
(76.1%) 
506 
(80.4%) 
0.54 
Psychological 
Counselling 
67 
(63.2%)◊ 
76 
(80.0%)◊ 
78 
(77.2%) 
221 
(73.2%)† 
528 
(82.5%) 
0.09 
Electronic patient 
charting 
58 
(63.7%) 
48 
(58.5%) 
70 
(70.7%) 
176 
(64.7%) 
294 
(59.3%) 
0.86 
Individual consult with 
a nurse 
42 
(40.8%)◊◊◊ 
70 
(74.5%)◊◊◊ 
65 
(65.7%) 
177 
(59.8%)†† 
536 
(84.0%) 
<0.001 
Assessment of strength 
66 
(64.7%) 
49 
(52.1%) 
57 
(56.4%) 
172 
(57.9%) 
273 
(43.5%) 
0.26 
Alternative forms of 
exercise (e.g., yoga, 
dance) 
44 
(41.9%) 
46 
(48.9%) 
50 
(51.0%) 
140 
(47.1%) 
213 
(33.7%) 
0.34 
Women-only classes 
17 
(16.2%) 
19 
(20.4%) 
18 
(18.2%) 
55 
(18.3%) 
55 
(8.7%) 
0.07 
Other 
20 
(39.2%) 
22 
(33.8%) 
24 
(36.4%) 
66 
(36.3%) 
46 
(20.1%) 
0.01 
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Total Elements  
(mean ± SD / 27)§ 
18.2 ± 4.2 18.2 ± 4.9 18.3 ± 4.5 18.2 ± 4.5 18.9 ±3.8 0.18 
Total core (/11)§ 6.7 ± 2.6 6.7 ± 2.5 7.0 ± 2.4 7.3 ± 1.8 7.9 ± 1.7 <0.01 
*Generalized Linear Mixed Models were used to test for significant differences in LMICs versus 
HICs. 
† p< 0.05; †† p< 0.01; ††† p< 0.001 for Generalized Linear Mixed Models testing for significant 
differences by most common funding source;  
ǁrespondents did not provide information on funding source for CR in 9/335 surveys 
For pairwise comparisons ◊: one symbol=p<0.05; two symbols=p<0.01; 3 symbols=p<0.001 
¶Significantly different from all funding sources (p<0.001). 
CV=cardiovascular; HIC= high-income country; LMIC= low- and middle-income country; SD= 
standard deviation 
§components offered in all models of CR counted as 1 and Components offered in some CR 
models counted as 0.50. 
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Table 8: Cardiac Rehabilitation Dose by Country Income Classification and Funding Source, 
N=1082 
 
LMIC 
 
HIC 
(n=747) 
 
p* 
 
Private 
(n=103) 
Public 
(n=115) 
Hybrid 
(n=108) 
Total† 
(n=326)ǁ 
  
Duration (weeks) 10.8±6.9 14.1±13.5¶ 10.8±9.6 11.7±10.2††† 10.4±9.0 0.07 
Frequency (per 
week) 
2.9±1.0 2.8±1.3 2.8±1.2 2.8±1.1 2.4±1.1 <0.001 
Total Sessions / 
program 
31.0±19.7 
42.2±44.0 
¶ 
29.4±25.1 
33.7±30.7 
††† 
25.9±24.9 <0.001 
Minutes (per 
session) 
56.7±19.5 54.8±24.6 57.4±20.8 56.4±21.5  60.0±17.7 <0.01 
Total 
hours/program 
29.3±20.1 43.2±52.4¶ 28.7±24.7 33.2±34.5††† 26.6±25.2 <0.001 
ǁrespondents did not provide information on funding source for CR in 9/335 surveys.  
*Mann-Whitney U was used to test for significant differences in LMICs versus HICs. 
† p< 0.05; †† p< 0.01; ††† p< 0.001 for Generalized Linear Mixed Models testing for significant 
differences by most common funding source; 
For pairwise comparisons: one symbol=p<0.05; two symbols=p<0.01; 3 symbols=p<0.001 
¶Significantly different from all funding sources (p<0.001). 
HIC= high-income country; LMIC= low- and middle-income country 
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Table 9: Barriers to Cardiac Rehabilitation Delivery by Income Classification and Funding 
Source, N=1082 
 
 
LMIC 
HIC 
(n=747) 
p* 
 Private 
(n=103) 
Public 
(n=115) 
Hybrid 
(n=108) 
Total† 
(n=326)ǁ 
  
Patient Referral 4.2±1.3ǂǂ 3.4±1.5ǂǂ 3.7±1.4 3.8±1.4†† 3.1±1.5 0.001 
Financial Resources 3.4±1.5 3.5±1.5 3.6±1.4 3.5±1.5 3.5±1.4 0.91 
Human Resources 2.5±1.4¶ 3.4±1.4 3.0±1.4 3.0±1.5††† 3.3±1.4 0.74 
Space 2.4±1.4ǂ 3.0±1.5ǂ 2.7±1.4 2.7±1.5† 2.8±1.5 0.38 
Equipment 2.1±1.3ǂǂ 2.9±1.5ǂǂ 2.5±1.4 2.5±1.4†† 2.4±1.3 0.14 
ǁrespondents did not provide information on funding source for CR in 9/335 surveys.  
*Generalized Linear Mixed Models were used to test for significant differences in LMICs versus 
HICs. 
† p< 0.05; †† p< 0.01; ††† p< 0.001 for Generalized Linear Mixed Models testing for significant 
differences by most common funding source; 
For pairwise comparisons ǂ=p<0.05; ǂǂ=p<0.01; ǂǂǂ=p<0.001 
¶Significantly different from all funding sources (p<0.001). 
HIC= high-income country; LMIC= low- and middle-income country 
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Table 10: Sources of Cardiac Rehabilitation Program Funding by Country Income Classification, 
N=1082 
 LMIC 
(n=335) 
HIC 
(n=747) 
p* 
Patient 212 (65.0%) 184 (24.9%) <0.001 
Social Security / Government 179 (54.9%) 444 (60.2%) 0.11 
Hospital / Clinical Center 61 (18.7%) 250 (33.9%) <0.001 
Private Health Insurance 105 (32.2%) 167 (22.6%) 0.001 
Other 6 (1.8%) 48 (6.5%) 0.001 
*chi-square tests were used to test for significant differences in LMICs versus HICs  
HIC= high-income country; LMIC= low- and middle-income country 
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APPENDICES 
Appendix A: Consent Form		
	
	  
V4; Jul 4/2016 
Page 1 
 
 
 
GLOBAL CARDIAC REHABILITATION PROGRAM SURVEY 
 
Consent form 
 
You are being asked to participate in a research study to understand the availability and characteristics of 
cardiac rehabilitation programs globally. You are being asked to participate because you are the most 
responsible clinician or administrator of a cardiac rehabilitation program.  
 
What You Will Be Asked to Do in the Research:  
If you agree to participate, you will be asked to respond to an online survey that takes about 20 minutes to 
complete.  
Data will be collected primarily via online survey. Phone or paper administration may be possible in some 
instances if you do not have internet access and are willing to provide your information in this manner.  
 
Confidentiality: 
All information you supply during the research will be held in confidence, and your name will not appear 
in any report or publication of the research.  
 
Your data will be safely stored. Each completed survey will only be identifiable by a unique research 
identification number. Electronic survey responses will be stored on a secure database. It will not be stored 
on any portable media. Only the research team will have access to the collected information. The Principal 
Investigators will destroy the data 15 years after the completion of the project: the electronic database will 
be deleted from the system. Confidentiality will be provided to the fullest extent possible by law. 
 
Benefits of the Research and Benefits to You:  
This research is designed to understand the availability of cardiac rehab, particularly in low- and middle-
income countries where there is a growing burden of cardiovascular disease. We hope to use the findings 
to inform policy in international and national fora, on the status of and gaps in cardiac rehabilitation.  
 
If you are interested, we will provide you with comparative information about the characteristics of other 
cardiac rehabilitation programs in your country or region. This information may be of use to you in 
advocating for CR services in your region. 
 
You will not receive payment for your participation. 
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Risks and Discomforts:  
We do not foresee any risks or discomfort from your participation in the research. You 
may refuse to answer any question(s) that you do not wish to answer.  
 
Voluntary Participation:  
Your participation in the study is voluntary and you may choose to stop participating at 
any time. Your decision not to volunteer will not influence the nature of the ongoing 
relationship you may have with the researchers, or study staff, or the nature of your 
relationship with York University of the Mayo Clinic either now, or in the future. You 
have the right to withdraw your consent or discontinue participation at any time without 
penalty.  
 
Questions About the Research?  
If you have questions about the research in general or about your role in the study, please 
feel free to contact Dr. Sherry Grace either by telephone at (416) 736-2100, extension 
22364 or by e-mail (sgrace@yorku.ca) or Marta Supervia Pola by e-mail 
(globalcr@mayo.edu)  
 
This research has been reviewed and approved by the Human Participants Review Sub-
Committee, York University's Ethics Review Board, and conforms to the standards of the 
Canadian Tri-Council Research Ethics guidelines. If you have any questions about this 
process or about your rights as a participant in the study, please contact the Sr. Manager 
& Policy Advisor for the Office of Research Ethics, 5th Floor, York Research Tower, 
York University (telephone 416-736-5914 or e-mail ore@yorku.ca). In addition, if you 
have any concerns, complaints, or general questions about research or your rights as a 
participant, please contact the Mayo Institutional Review Board (IRB) to speak to 
someone independent of the research team at 507-266-4000 or toll free at 866-273-4681.  
 
Legal Rights and Consent: 
 
I consent to participate in "Global Cardiac Rehabilitation Survey: Availability and 
Characteristics of Programs" conducted by Drs. Sherry Grace & Francisco Lopez. I have 
understood the nature of this project and wish to participate. I am not waiving any of my 
legal rights by completing this form. My checkmark below indicates my consent. 
 
 
  I consent  
 
 
Today's date: ______________________ (dd/mmm/yyyy) 
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Appendix B: Survey  
CARDIAC REHABILITATION PROGRAM QUESTIONNAIRE  
 
 
1. What is your Title/Position at the cardiac rehabilitation program? (check	Pone): 
c Director 
c Coordinator / Manager / Supervisor 
c Clinician, specify: __________________________ 
c Other, specify: __________________________________________________ 
 
SECTION A: GENERAL INFORMATION  
 
2. In what country is your cardiac rehabilitation program? ______________ 
3. City / Region: ___________________(optional) 
4. Your	cardiac	rehabilitation	program	is	located	in	an: 
  Urban	area	(e.g.larger	cities,	towns)	
  Suburban	(a	residential	district	located	on	the	outskirts	of	a	city)	
  Rural	area	or	countryside	(a	geographic	area	that	is	located	outside	towns	and	
cities).	
5. In	what	year	was	your	cardiac	rehabilitation	program	initiated?	_______	(year)	
6. Who	pays	for	cardiac	rehabilitation	?	(Check	all	that	apply)		
c Social security / government 
c Hospital or  clinical center where the cardiac rehab service is based  
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c Patient (answer 6b & c)        
c Private health insurance  
c Other (specify): _____________________  
 
6b. What is average percent of the total program cost that patients pay, if they complete the 
program?  
 
_____ %             OR					□	I	don’t	know	
       6c. What	is	the	direct	cost	to	patients	to	participate,	if	they	complete	the	program?		
	
_____________				___________		OR					□	I	don’t	know	
Amount		 	 currency	
7. Is your cardiac rehabilitation program located within a hospital (check Pone)? 	
c Yes	–	it	is	in	a	referral	centre/	quarternary	/	tertiary	facility	and	/	or	academic	centre	
c Yes	–	it	is	in	a	community	hospital	
c Yes	-		it	is	in	a	rehabilitation	hospital/	residential	facility	
c Yes	–	other	(please	specify:	_______________________________________)	
c No	(skip	to	question	10)	
	
8. If	Q7	was	marked	yes,	does the hospital have an inpatient cardiology service?  Check one 
box:  
c Yes, and these patients are referred to our cardiac rehabilitation program regularly 
c Yes, and these patients are sometimes referred to our cardiac rehabilitation program 
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c Yes, and these patients are rarely referred to our cardiac rehabilitation program  
c No    
 
9. If Q7 and Q8 were marked yes, do they offer? (check all that apply) 
c Revascularization via percutaneous coronary intervention (PCI)  
c Coronary artery bypass graft surgery (CABG)  
c Percutaneous valve implantation 
c Implantable	heart	devices	(pacemakers	or	defibrillators) 
c Cardiac transplant 
c None 
 
10. In what department is the cardiac rehabilitation program situated administratively? 
  Cardiology department 
  Physical Medicine and Rehabilitation department 
  Internal Medicine department 
  Primary / general practice 
  It is in a community facility 
  None – it is stand-alone 
  Other (specify) :_________________________ 
 
11. For patients referred following a cardiac hospitalization, on average how many weeks after 
discharge does a patient start your program? (i.e., initial assessment appointment)  
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__________	weeks	
	
12. How	many	unique	cardiac	rehabilitation	patients	do	you	provide	service	to	each	year	in	
your	program?		
	
_________	patients	per	year		
	
	
13. How	many	patients	do	you	have	capacity	to	serve	each	year,	in	terms	of	staff	and	space?		
_____________	patients	per	year			
	
14. What	is	the	cost	to	your	program	to	serve	one	(1)	patient,	if	they	complete	the	program?		
	
_____________				___________		OR					□	I	don’t	know	
Amount		 	 currency	
	
15. Who	can	refer	a	patient	to	your	program?	Check	all	that	apply	
c Patients	can	self-refer	
c Physicians	
c Allied	healthcare	providers	and	/	or	nurses	
c Community	health	care	workers	
c Other,	please	specify:	___________________________________	
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16. 	Are	there	any	other	Cardiac	Rehabilitation	programs	in	your	area?	Check	one	box	
c Yes,	within	approximately	a	20	km	radius	
c Yes,	but	more	than	20	km	away	
c None		
c I	don’t	know	
	
17. Please rate the degree to which each of the following are barriers to greater patient 
participation in your cardiac rehab program, from “this is definitely not an issue” to “this is 
a major issue”: Check	one	per	row. 
	
This is definitely not an 
issue 
1 
This is not an 
issue 
2 
Neutral 
3 
This is a minor 
issue 
4 
This is a 
major issue 
5 
	
 
Lack of patient referral      
 
Lack of equipment  
(specify:______) 
     
 
Lack of space      
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Lack of human resources       
 
Lack of financial resources/ 
budget 
     
 
Other (specify:____________) 
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SECTION	B:	DETAILS	ABOUT	YOUR	CARDIAC	REHABILITATION	PROGRAM	
	
18. Who has overall responsibility for cardiac rehabilitation at your program? Please check one 
box:  
c Cardiologist 
c Physician specialist in internal medicine 
c Physical medicine and rehabilitation (physiatrist) 
c Physician, other specialty (please specify: _______________________________) 
c Nurse 
c Exercise physiologist 
c Physiotherapist  
c Other (specify)_________________________ 
	
19. How	expensive	are	the	following	aspects	of	delivering	your	cardiac	rehab	program?	(check	
one	box	per	row)	
 
 Free Only a 
minor 
cost 
Costs 
a bit 
costs 
quite 
a bit 
Very 
expensive 
Not 
applicable 
as we do 
not have 
this 
a. Front-line personnel       
b. Space       
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c. Exercise equipment       
d. Equipment / supplies for 
cardiovascular risk assessment 
(not including exercise stress 
tests) 
      
e. Exercise stress testing on a 
treadmill or cycle ergometer 
      
f. Patient education materials       
g. Blood pressure assessment 
device 
      
h. Blood collection and lipid testing       
i. Free weights etc. for resistance 
training 
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20. Which of the following components of cardiac rehabilitation are provided in your program? 
If they are provided, are they provided in all the models you deliver? (i.e., supervised and 
home-based programs)?  
 
Please check one box per row. If you only offer one model of rehabilitation and you offer the 
listed component, please check “yes, in all models”.  
 Yes  
In all 
models 
Yes 
For some 
models 
No 
Initial assessment    
Individual consultation with a physician    
Individual consultation with a nurse    
Exercise stress test    
Other functional capacity test (please specify:  
_______________________________) 
   
Assessment of strength (e.g., handgrip)     
Assessment for comorbidities / issues that could 
impact exercise (e.g., cognition, vision, 
musculoskeletal / mobility issues, frailty, and / 
or balance / falls risk) 
   
Exercise prescription    
Physical activity counseling    
Supervised exercise training    
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Heart rate measurement training for patients     
Resistance training     
Management of cardiovascular risk factors    
Prescription and/or titration of secondary 
prevention medications 
   
Nutrition counseling    
Depression screening    
Psychological counseling     
Smoking cessation sessions/classes    
Vocational counseling / support for return-to-
work 
   
Stress management / Relaxation techniques    
Alternative forms of exercise, such as yoga, 
dance, or tai chi (please specify: ___________) 
   
Women-only classes    
End of program re-assessment    
Electronic patient charting    
Communication of patient assessment results 
with their primary care provider                                         
   
Follow-up after outpatient program    
Other (please specify): ________________    
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21. How many education sessions are provided to each patient in your program?     _____ (enter 
zero if none)	
	
22. How	many	minutes	on	average	is	each	education	session?	______	minutes	(enter	zero	if	
none)	
 
23. In your program, do you assess the following risk factors? Please check one box per row. 	
 Yes No 
Time spent being sedentary   
Tobacco use   
Harmful use of alcohol   
Blood pressure   
Body mass Index   
Waist circumference   
Hip circumference   
Body composition   
Total Cholesterol   
Cholesterol fractions (HDL-c, LDL-c)   
Triglycerides   
HbA1c for diabetic patients   
Blood glucose for non-diabetic patients   
Sleep apnea   
Depression / Anxiety   
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Physical inactivity   
Poor diet   
Other (please specify:_______________)   
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24. Which types of personnel are part of your cardiovascular rehabilitation (CR) team? If they 
are part of your team, do they work in Cardiac Rehabilitation only, or do they have other 
department obligations? (Check one box in each row): 	
 
a. Cardiologist                             Yes- only CR (   )   Yes- partial (   )   
No   (   )   
b. Physiatrist (Physical medicine and rehabilitation) Yes- only CR (   )   Yes- partial (   )   
No   (   )   
c. Sports Medicine Physician               Yes- only CR (   )   Yes- partial (   )   
No   (   ) 
d. Other Physician (specify:___________________) Yes- only CR (   )   Yes- partial (   )   
No   (   ) 
e. Physiotherapist                             Yes- only CR (   )   Yes- partial (   )   
No   (   ) 
f. Nurse       Yes- only CR (   )   Yes- partial (   )   
No   (   ) 
g. Nurse practitioner           Yes- only CR (   )   Yes- partial (   )   
No   (   ) 
h. Psychiatrist                                 Yes- only CR (   )   Yes- partial (   )   
No   (   ) 
i. Psychologist                                Yes- only CR (   )   Yes- partial (   )   
No   (   ) 
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j. Social worker            Yes- only CR (   )   Yes- partial (   )   
No   (   ) 
k. Dietitian                             Yes- only CR (   )   Yes- partial (   )   
No   (   ) 
l. Kinesiologist      Yes- only CR (   )   Yes- partial (   )   
No   (   )   
m. Pharmacist      Yes- only CR (   )   Yes- partial (   )   
No   (   ) 
n. Exercise specialist     Yes- only CR (   )   Yes- partial (   )   
No   (   ) 
o. Community Health worker    Yes- only CR (   )   Yes- partial (   )   
No   (   ) 
p. Administrative assistant/ Secretary   Yes- only CR (   )   Yes- partial (   )   
No   (   ) 
q. Other (specify): ______________________             Yes- only CR (   )   Yes- partial (   )   
No   (   )  
	
25. Do	all	your	clinical	staff	supervising	patients	during	exercise	sessions	have	cardiopulmonary	
resuscitation	(CPR)	training	/	certification?	
c Yes		
c No	(skip	to	question	26)	
	
25b. If yes, are they required to renew their CPR training regularly? 
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c Yes	
c No	
	
25c.	If	yes,	is	the	CPR	certification	advanced	or	basic?	(circle	one	per	row)	
Physicians:										Advanced	 	 Basic	
Nurses:							 				Advanced	 	 Basic	
Other:	 															Advanced	 	 Basic 
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26. Does your program have each of the following ítems, and if yes, is its’ use dedicated to your 
program or shared with another group (circle one option in each row)?  
 
Bicycle ergometer   Dedicated Shared  Not available 
Treadmill ergometer   Dedicated Shared  Not available 
Arm cycloergomenter   Dedicated Shared  Not available 
Doppler Echocardiography  Dedicated Shared  Not available 
Stress test (no O2)   Dedicated Shared  Not available 
Stress test with O2  Dedicated Shared  Not available 
Telemetry     Dedicated Shared  Not available 
Group education room   Dedicated Shared  Not available 
Gym space   Dedicated Shared  Not available 
Individual assessment/  Dedicated Shared  Not available 
Counselling room 
Patient change room  Dedicated Shared  Not available 
Administrative office  Dedicated Shared  Not available 
Electronic patient charts  Dedicated Shared  Not available 
Resistance training equipment Dedicated Shared  Not available 
Body composition analyzer  Dedicated Shared  Not available 
Staff meeting room  Dedicated Shared  Not available 
Staff office space   Dedicated Shared  Not available 
Other (specify):   Dedicated Shared  Not available 
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27. Does	your	site	offer	a	supervised	Cardiac	Rehabilitation	program?	
  
c Yes   
c No (skip to section D) 
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SECTION	C:	CARDIAC	REHABILITATION	–	Supervised	Program	
	
28. Which of the following cardiac diagnoses or indications do you accept for your supervised 
program? (Check all that apply)  
c Post Myocardial Infarction / acute coronary syndrome   
c Stable coronary artery disease, without a recent event or procedure          
c Post percutaneous coronary intervention (PCI)   
c Post coronary artery bypass graft surgery (CABG)  
c Heart failure    
c Patients who have had valve surgery/repair or transcatheter aortic valve implantation 
(TAVI)  
c Heart transplant  
c Patients with ventricular assist devices 
c Arrhythmias (hemodynamically-stable) 
c Patients with implanted devices for rhythm control  (i.e., ICD / CRT, pacemaker)           
c Congenital heart disease 
c Cardiomyopathy 
c Rheumatic heart disease   
c Patients at high-risk of cardiovascular disease (primary prevention) 
c Non-cardiac chronic diseases 
c Other (specify): ____________________ 
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29. Which of the following non-cardiac diagnoses or indications do you accept for your on-site 
program? (Check all that apply)   
c Stroke 
c Intermittent claudication / peripheral vascular disease 
c Cancer 
c Diabetes 
c Chronic lung disease 
c None 
c Other (specify): ____________________ 
 
30. Which of the following patient levels of cardiac risk do you accept for your supervised 
program?  (Check all that apply) 
c Low 
c Moderate 
c High 
c Not applicable because we do not risk stratify at our program 
 
31. Do	patients	have	an	individual	consult	with	a	physician	during	the	program?		
  Yes, please specify # times in a full program: ______ 
  No 
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32. What	is	the	standard	duration	of	the	on-site	cardiac	rehabilitation	program	that	you	
provide	to	patients?	
__________	weeks		
	
33. On	average,	for	how	many	sessions	do	patients	come	on-site	each	week?		
	
__________	sessions	per	week	OR	_____	sessions	/	day	(residential	
programs)	
 
34. On average, how many patients are in each exercise session?  
 
 __________ patients / session  
 
35. On average, how long is each exercise session (including warm up, aerobic exercise, 
strength training and/ or cold down)?  
 
_______________ minutes / session 
 
36. What is the maximum number of patients that your program allows in the same exercise 
session? 
 
__________ patients / session 
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37. What is the staff to patient ratio during supervised exercise at your program? _____:______ 
patients 
 
38. Which healthcare professionals are usually present during exercise sessions? (Check one 
box in each row)  
 
a. Cardiologist                             Yes (   )   No   (   )   
b. Physiatrist (Physical Medicine and Rehabilitation) Yes (   )   No   (   )   
c. Sports Medicine Physician               Yes (   )   No   (   )   
d. Other Physician (specify:___________________) Yes (   )   No   (   )   
e. Physiotherapist                             Yes (   )   No   (   )   
f. Nurse       Yes (   )   No   (   )   
g. Nurse practitioner           Yes (   )   No   (   )   
h. Psychiatrist                                 Yes (   )   No   (   )   
i. Psychologist                                Yes (   )   No   (   )   
j. Social worker            Yes (   )   No   (   )   
k. Dietitian                             Yes (   )   No   (   )   
l. Kinesiologist      Yes (   )   No   (   )   
m. Pharmacist      Yes (   )   No   (   )   
n. Exercise specialist     Yes (   )   No   (   )   
o. Community health worker    Yes (   )   No   (   )   
p. Other (specify): ______________________________________    
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39. Does	the	supervised	program	offer	telemetry	or	another	method	of	monitoring	patients’	
clinical	status	while	exercising?	(check	all	that	apply)	
c Yes,	telemetry	
c Yes,	other	method	of	monitoring;	please	specify:	
c Borg	scale	(perceived	exertion)	
c Heart	rate	
c Other:	______	
c None	
 
 
	
SECTION D- ALTERNATIVE MODELS OF CARDIAC REHABILITATION DELIVERY  
	
40. Are	alternative	cardiac	rehabilitation	models	such	as	home-based,	reimbursable	by	
government	or	insurance	companies	in	your	region?		
  Yes;	please	specify	which	model(s):___________________________	
  No	
	
41. Does	your	cardiac	rehabilitation	program	offer	alternative	models	of	program	delivery	than	
an	on-site	program?		
c Yes	
c No		
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41b.	If	Q41	was	marked:	yes,	please	specify	(check	all	that	apply):		
c Home-based	(includes	web	or	Smartphone-based)	
c Community-based		
c Hybrid	of	supervised	with	home	or	community-based		
c Other,	specify:	______________________________	
	
If	Q41b	was	marked:	home–based	program,	please	answer	the	following	questions:		
	
42. When	did	it	start?	________	(year)	
	
43. What	proportion	of	your	patients	are	served	in	a	home-based	program?		
	
______	%	
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44. Do	you	perceive	your	program	has	sufficient	capacity	to	meet	need/demand	in	the	home-
based	model?	(check	on	box)	
c Yes	
c No	
	
44b.	If	NO,	please	specify	the	reason	(check	all	that	apply):	
c Not	enough	funding	
c Not	enough	staff	
c Not	enough	other	resources	
c Patients’	risk	too	high	for	unsupervised	exercise	
c Other.	Please,	specify:	___________________________________	
	
45. What	is	the	standard	duration	of	the	home-based	cardiac	rehabilitation	program	that	you	
provide	to	patients?		
__________	weeks	
	
46. On	average,	for	how	many	sessions	(i.e.,	formal	contact	with	the	Cardiac	Rehabilitation	
staff)	do	patients	complete	in	the	home-based	program	each	month?		
	
__________	sessions	/	month	
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47. On	what	basis	are	patients	offered	a	home-based	program?	(check	all	that	apply)	
  Risk	stratification	
  Patient	indication	
  Distance	to	centre	
  Time	or	work	constraints	during	the	Cardiac	Rehabilitation	centre	hours	
  Transportation	barriers	
  Patient	choice	
  Cost	
  Other,	please	specify:	_________________________	
	
48. Does	the	home-based	program	offer	telemetry	or	another	method	of	monitoring	patients’	
clinical	status	while	exercising?	(check	all	that	apply)	
c Yes,	telemetry	
c Yes,	other	method	of	monitoring;	please	specify:		
c Borg	scale	(perceived	exertion)	
c Heart	rate	
c Other:	______	
c None	
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49. Do	participants	in	your	home-based	program	receive	any	materials	to	support	them	in	the	
program?	(check	all	that	apply)	
c Yes,	they	receive	an	activity	tracker	(e.g.,	pedometer,	accelerometer,	log	book)	
c Yes,	they	receive	resistance	training	materials	(e.g.,	therabands,	dumbbells)	
c Yes,	they	receive	education	materials	(e.g.,	workbook)	
c Yes,	they	receive	other	materials	(please	specify:___________________________)	
c Sometimes	(please	specify:	
________________________________________________)	
c No	
	
50. Which of the following patient levels of cardiac risk do you accept for your home-based 
program?  (Check all that apply) 
c Low 
c Moderate 
c High 
c Not applicable because we do not risk stratify at our program 
 
51. What	forms	of	communication	are	used	with	patients	in	your	home-based	program?	
(check	one	box	per	row,	to	report	the	frequency)	
	
	 Never	 Daily	 Several	 Weekly	 Several	 Monthly	 Just	
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Times/week	 times	/	
month	
once	
Internet	webpage	 	 	 	 	 	 	 	
email	 	 	 	 	 	 	 	
webcam	 	 	 	 	 	 	 	
Mobile	phone	 	 	 	 	 	 	 	
Smartphone	app	 	 	 	 	 	 	 	
Text	messages	 	 	 	 	 	 	 	
Log	or	diary	(paper)	 	 	 	 	 	 	 	
Telephone	(landline)	 	 	 	 	 	 	 	
In-person	/	on-site	visit	 	 	 	 	 	 	 	
Other	(please	specify:	
_____________________)	
	 	 	 	 	 	 	
	
52. Did	you	perceive	any	barriers	to	using	these	communication	tools?		
c No	
c Yes.	If	yes,	please	specify	(check	all	that	apply):	
c Logistical	problems:	i.e.,	connection	
c Lack	of	patient	access	(i.e.,	patients	do	not	have	computer	with	
email)	
c Difficulty	for	the	clinical	staff	(specify:_____________________)	
c Difficulty	for	the	patients	(specify:	_____________________)
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c Other	(specify):________________________	
	
53. Which providers interact directly with the patients in the home-based cardiac rehabilitation 
program? Please check all that apply:  
  Physician, specify specialty: _________________________________  
  Nurse 
  Exercise physiologist 
  Physiotherapist  
  Other (specify)_________________________ 
	
54.  What do you think you would need to be ready and able to significantly increase your 
program’s capacity to provide home-based cardiac rehabilitation services to patients?  
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
_____________________	
	
	
If	Q41b	was	marked:	Community-based	program,	please	answer	the	following:		
	
55. Where	does	the	community-based	program	take	place?	
c Public	center	
c Private	center		
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c Semi-private	center	
c Other:	_______________________	
	
56. When	did	it	start?	________	(year)	
	
57. What	proportion	of	your	patients	are	served	in	the	community-based	program?		
	
______	%	
58.	On	average,	how	many	patients	are	in	each	exercise	session?		
 
 __________ patients / session  
 
59.	How	many	classes	do	you	offer	in	a	week?									____________	sessions	
	
60.	Which	of	the	following	patient	levels	of	cardiac	risk	do	you	accept	for	your	community-
based	program?		(Check	all	that	apply)	
c Low 
c Moderate 
c High 
c Not applicable because we do not risk stratify at our program 
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61.	Which	type	of	provider	is	most	responsible	to	supervise	the	Community-based	exercise	
sessions?	Please	check	one	box:		
c Physician type – please specify: ______________________________ 
c Nurse 
c Exercise physiologist 
c Physiotherapist  
c Other (specify)_________________________ 
 
62.	What	is	the	standard	duration	of	the	community-based	cardiac	rehabilitation	program	that	
you	provide	to	patients?		
__________	weeks		
	
63	On	average,	for	how	many	sessions	do	patients	complete	in	the	community-based	program	
each	month?		
__________	sessions	per	month	
	
64.	On	what	basis	are	patients	offered	a	community-based	program?	(check	all	that	apply)	
  Risk	stratification	
  Patient	indication	
  Distance	to	main	Cardiac	Rehabilitation	centre	
  Time	or	work	constraints	during	the	Cardiac	Rehabilitation	centre	hours	
99	
  Transportation	barriers	
  Patient	choice	
  Cost	
  We	do	not	have	a	main	centre	in	a	clinical	setting	
  Other,	please	specify:	_________________________	
	
	
65.	Does	the	community-based	program	offer	telemetry	or	another	method	of	monitoring	
patients’	clinical	status	while	exercising?	(check	all	that	apply)	
c Yes,	telemetry	
c Yes,	other	method	of	monitoring;	please	specify:		
c Borg	scale	(perceived	exertion)	
c Heart	rate	
c Other:	______	
c None	
	
66.	What	do	you	think	you	would	need	to	be	ready	and	able	to	significantly	increase	your	
program’s	capacity	to	provide	community-based	cardiac	rehabilitation	services	to	patients?		
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
____________ 
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Thank you most sincerely on behalf of the International Council of Cardiovascular Prevention and 
Rehabilitation for the time and expertise you have committed to complete this important questionnaire.  
In return for your participation, we would like to offer you some information describing the nature of cardiac 
rehabilitation as delivered in your country / region. This may be useful to your program.  
Please note, we will not have the opportunity to compile this information and share it with you until we have 
finished collecting data from as many programs as possible. 
 
If you would like to receive this information via email, please check this box 
  Yes, I would like to receive information describing the nature of cardiac rehab delivered in my country / 
region 
 
 
Please provide an email address to receive this information: _________________________________   
 
	
 
 
	
 
	
